Clinical Trials: Neoplasms

Bessemer : Birmingham Hematology and Oncology Associates, LLC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Birmingham : Research Site Updated

A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

Birmingham : Birmingham Hematology and Oncology Associates, LLC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Birmingham : Urology Centers of Alabama, PC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Birmingham : University of Alabama at Birmingham

ChemoFx® PRO - A Post-Market Data Collection Study

View More »

Birmingham : 1200.75.10013 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Birmingham : University Of Alabama at Birmingham

Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy

Birmingham : University of Alabama at Birmingham

Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors

Birmingham : University of Alabama at Birmingham

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Homewood : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Homewood : Urology Center of Alabama

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Mobile : USA Mitchell Cancer Institute

A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer

Mobile : USA Mitchell Cancer Institute

ChemoFx® PRO - A Post-Market Data Collection Study

Mobile : Southern Cancer Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Anchorage : Alaska Clinical Research Center, Llc

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Anchorage : Alaska Clinical Research Center, LLC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Anchorage : Alaska Clinical Research Center, LLC Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Anchorage : Alaska Regional Hospital

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Chandler : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Chandler : New Horizons Women's Care, LLC

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Goodyear : Weatern Regional Medical Center / Cancer Treatment Centers of America

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Phoenix : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Phoenix : Arizona OB/GYN Affiliates, PC

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

View More »

Phoenix : Precision Trials

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Phoenix : BCG Oncology, PC Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Phoenix : Barrow Neurological Institute, St. Joseph's Hospital and Medical Center

In Vivo Confocal Microscopy Tumor Atlas Study

Phoenix : HOPE Research Institute

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Scottsdale : Investigational Site Number 840002

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

Scottsdale : Scottsdale Clinical Research Institute

A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors

Scottsdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Dose-Escalation Study in Participants With Advanced Cancer

Scottsdale :

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Scottsdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Phase 1 Study in Advanced Cancer

Scottsdale : Scottsdale Healthcare, Site #134

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113

Scottsdale : Mayo Clinic

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Scottsdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Scottsdale : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Scottsdale : Mayo Clinic Updated

A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies

Scottsdale : TGen Clinical Research Services at Scottsdale Healthcare

A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors

Scottsdale :

BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer

Scottsdale : Novartis Investigative Site

Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors

Scottsdale : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Scottsdale : Investigational Site Number 840003

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

Scottsdale :

Dose Escalation Study of INK128 in Subjects With Advanced Cancer

Scottsdale : TGEN Clinical Research Services at Scottsdale Healthcare

Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors

Scottsdale : TGEN Clinical Research Services at Scottsdale Healthcare

Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors

Scottsdale : Mayo Clinic Arizona

Dose-escalation Study of Oral CX-4945

Scottsdale : Investigational Site

Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma

Scottsdale : TGen Clinical Research Service at Scottsdale Healthcare

Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors

Scottsdale : Mayo Clinic in Arizona

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Scottsdale : Mayo Clinic Scottsdale

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Scottsdale : Virginia G. Piper Cancer Center at Scottsdale Healthcare

Oral Azacitidine as a Single Agent and in Combination With Carboplatin or Abraxane® in Subjects With Relapsed or Refractory Solid Tumors

Scottsdale : Pinnacle Oncology

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

Scottsdale :

Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With MEK (Mitogen-activated Protein Kinase) Inhibitor BAY86-9766 in Patients With Advanced Cancer

Scottsdale : Mayo Clinic Cancer Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Scottsdale : TGen Clinical Research Service at Scottsdale Healthcare

Safety Study of PLX108-01 in Patients With Solid Tumors

Scottsdale : Site Reference ID/Investigator# 64046

Study of ABT-700 in Subjects With Advanced Solid Tumors

Scottsdale : TGen Clinical Research Services at Scottsdale Healthcare

Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma

Scottsdale : TGen Clinical Research Services Updated

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Scottsdale :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Scottsdale : TGen Clinical Research Service

Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors

Scottsdale : Arizona TGen Clinical Research Services at Scottsdale Heathcare

Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors

Scottsdale : Ramesh K. Ramanathan M.D.

Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors

Scottsdale : Mayo Clinic - Scottsdale

Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors

Scottsdale : Pinnacle Hematology Oncology

Study of PWT33597 Mesylate in Subjects With Advanced Malignancies

Scottsdale : Pinnacle Oncology Hematology

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Scottsdale :

Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors

Tucson : Arizona Cancer Center

A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors

Tucson : Arizona Institute of Urology

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Tucson : Arizona Oncology Associates, PC - HOPE

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Tucson : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Tucson : Urology Associates of Southern Arizona

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Tucson : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Tucson : Visions Clinical Research - Tucson

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Tucson : Site Reference ID/Investigator# 53006

An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors

Tucson : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Tucson : Arizona Urologic Specialists Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Tucson : Desert Sun Clinical Research Updated

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Tucson : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Tucson : Desert Sun Clinical Research, LLC

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Tucson : Desert Sun Gastroenterology

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Tucson : Desert Sun Surgery Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Tucson : Arizona Clinical Research Center

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Tucson : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Tucson : Arizona Cancer Center

Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer

Tucson : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Tucson : The University of Arizona Cancer Center

Study of PWT33597 Mesylate in Subjects With Advanced Malignancies

Tucson : Southern Arizona VA Medical Center

The Study of Barrett's Esophagus: What Are the Factors of Progression

Tuscon : The University of Arizona Cancer Center

Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors

Fayetteville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Head and Neck Cancer

Fayetteville : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Fayetteville : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Fayetteville : Novartis Investigative Site Updated

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

Jonesboro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

View More »

Jonesboro : 1200.75.10034 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Jonesboro : Clopton Clinic Hematology/Oncology

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Little Rock : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Rogers : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Alhambra : 1200.75.10113 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Anaheim : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Bakersfield : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Bakersfield : Comprehensive Blood and Cancer Center

Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma

Bakersfield : Comprehensive Blood and Cancer Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

View More »

Berkeley : Alta Bates Summit Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Berkeley : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Bermuda Dunes : Desert Oasis Healthcare

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Beverly Hills : Research Site

A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors

Beverly Hills : Tower Cancer Research Foundation

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

Burbank : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Burbank : Urology Specialists of Southern California - Burbank Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Campbell : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Colton : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Corona : Wilshire Oncology Medical Group, Inc.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Corona : Compassionate Cancer Care Medical Group, Inc.

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Downey : Southern California Oncology

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Duarte : City of Hope National Medical Center

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Duarte : Site Reference ID/Investigator# 23283 Updated

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

Duarte : Site Reference ID/Investigator# 27743 Updated

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

Duarte : City Of Hope National Medical Center

A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Duarte : Novartis Investigative Site Updated

Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors

Duarte : City of Hope National Medical Center

Safety Study of CALAA-01 to Treat Solid Tumor Cancers

Duarte : City of Hope Medical Center

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer

Encinitas : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Encinitas : cCare - California Cancer Associatesfor Research Excellence

Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors

Encino : Urology Specialists of Southern California

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Encino : Urology Specialist of Southern California - Encino Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Fountain Valley : Robert A. Moss, M.D., F.A.C.P., Inc

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fountain Valley : 1200.75.10010 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Fresno : Cancer Care Associates

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Fullerton : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Fullerton : 1200.75.10112 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Fullerton : Southern California Oncology

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Glendora : Wilshire Oncology Medical Group, Inc.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Highland : Beaver Medical Group

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Indio : JFK Memorial Hospital

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

La Jolla : Research Site Updated

A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

La Jolla : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of LY2875358 in Patients With Advanced Cancer

La Jolla : Pfizer Investigational Site

A Study Of PF-04449913 In Select Hematologic Malignancies

La Jolla : The Rebecca and John Moores UCSD Cancer Center

A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver

La Jolla : Thornton Hospital

A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver

La Jolla : Moores UCSD Cancer Center

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

La Jolla : UCSD Medical Center - La Jolla

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

La Jolla : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

La Jolla : University of California, San Diego

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

La Jolla : Moores University of California San Diego Cancer Center

Safety and PK Study of RRx-001 in Cancer Subjects

La Jolla : University of California San Diego / Moores Cancer Center

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

La Mesa : Franklin D. Gaylis, M.D. Inc, dba MedResearch

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

La Mesa : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

La Mesa : Grossmont Center for Clinical Research

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

La Mesa : Cancer Center Oncology Medical Group

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

La Mesa : TriWest Research Associates

NP2 Enkephalin For Treatment of Intractable Cancer Pain

La Verne : Wilshire Oncology Medical Group, Inc.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Laguna Hills : South Orange County Medical Research Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Loma Linda : Investigational Site Number 840013 Updated

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Long Beach : 1200.75.10104 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Long Beach : VA Hospital

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Los Angeles : University of California

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Los Angeles : Investigational Site Number 840004

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

Los Angeles : Novartis Investigative Site

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

Los Angeles : Cedars-Sinai Medical Center

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Los Angeles : University of California Los Angeles

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Los Angeles : USC Norris Comprehensive Cancer Center

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Los Angeles : USC / Norris Comprehensive Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Los Angeles : Research Site

A Study of AMG 337 in Subjects With Advanced Solid Tumors

Los Angeles : Usc/Norris Comprehensive Cancer Center

A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Los Angeles : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of LY2875358 in Patients With Advanced Cancer

Los Angeles : Childrens Hospital Los Angeles

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

Los Angeles : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

Los Angeles : Novartis Investigative Site

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

Los Angeles : Usc/Norris Comprehensive Cancer Center

Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers

Los Angeles : Cedars-Sinai Medical Center

Combination Trial MSC1936369B With Temsirolimus

Los Angeles :

Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations

Los Angeles : American Institute of Research Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Los Angeles : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Los Angeles : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Los Angeles : 1200.75.10004 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Los Angeles : Healthcare Partners Medical Group

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Los Angeles : White Memorial Medical Center

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Los Angeles : University of Southern California, Norris Comprehensive Cancer Center Updated

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors

Los Angeles : UCLA Jonsson Comprehensive Cancer Center

Safety Study of CALAA-01 to Treat Solid Tumor Cancers

Los Angeles : UCLA

Safety Study of PLX108-01 in Patients With Solid Tumors

Los Angeles : Updated

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Los Angeles : USC / Norris Comprehensive Cancer Center

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Los Angeles : Keck Hospital of USC

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Los Angeles : LAC + USC Medical Center

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Los Angeles :

Sorafenib Long Term Extension Program (STEP)

Los Angeles : USC Norris Comprehensive Cancer Center

Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer

Los Angeles : Norris Comprehensive Cancer Center Updated

Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma

Los Angeles : Pfizer Investigational Site

Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Los Gatos : Bay Area Gynecologic Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

Lynwood : Southern California Oncology

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Marina del Rey : Prostate Oncology Speciality Inc.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Marina del Rey :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Mission Hills : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Mission Hills : Facey Medical Foundation

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Montclair : REMEK Research

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Montebello : 1200.75.10042 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Monterey : Monterey Bay GI Consultants Medical Group & Research Institute

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Monterey Park : Furtura Research

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Murrieta : Tri Valley Urology Medical Group

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Newport Beach : Gynecologic Oncology Associates

Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma

Newport Beach : Investigational Site Number 1526

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Oakland : Hematology Oncology Associates

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Orange : Hematology-Oncology Medical Group of Orange County, Inc.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Orange : Medical Oncology Care Associates (MOCA)

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Orange : The Center for Cancer Prevention and Treatment, St. Joseph Hospital

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Orange : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Orange : Chao Family Comprehensive Cancer Center

Study of Cabazitaxel Plus Bavituximab as Second-line Chemotherapy for Patients With Castration-resistant Prostate Cancer

Orange : University of California Irvine Medical Center

TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma

Orange : University of California Irvine

Tracking Renal Tumors After Cryoablation Evaluation

Oxnard : PMK Medical Group, Inc., DBA Ventura County Hematology Oncology Specialists

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Oxnard : Diverse Research Solutions

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Palm Springs : Desert Oasis Healthcare

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Palm Springs : Desert Regional Medical Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Pasadena : Wilshire Oncology Medical Group, Inc.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Pasadena : Huntington Memorial Hospital/Hill Breast Center

Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons

Pasadena : UCLA Pasadena Oncology

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Pasadena : South Pasadena Cancer Center

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer

Pleasant Hill : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Pomona : Wilshire Oncology Medical Group, Inc.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Rancho Cucamonga : Wilshire Oncology Medical Group, Inc.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Rancho Cucamonga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Rancho Mirage : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Rancho Mirage : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Rancho Mirage : Hope Square Surgical Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Redondo : Cancer Care Associates

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Redondo Beach : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Redondo Beach : 1200.75.10109 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Roseville : Sutter Roseville Medical Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Sacramento : Call for Information (Investigational Site 0006)

A Combination Therapy Study of MK2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010 AM5)

Sacramento : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

Sacramento : Radiological Associates of Sacramento

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Sacramento : Sutter Cancer Center / Sacramento Center for Hematology and Medical Oncology

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Sacramento : Sutter Memorial Hospital

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Sacramento : University of California Davis Cancer Center

Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors

Sacramento : University of California at Davis

Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer

San Bernardino : San Bernardino Urological Associates

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

San Diego : University of California, San Diego: Moores Cancer Center, Site #099

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113

San Diego : San Diego Clinical Trials

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

San Diego : Pfizer Investigational Site

A Study Of PF-04449913 In Select Hematologic Malignancies

San Diego : UCSD Medical Center

A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver

San Diego : Medical Oncology Associates - SD

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

San Diego : Sharp Rees-Stealy

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

San Diego : UCSD Medical Center - Hillcrest

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

San Diego : San Diego Clinical Trials Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

San Diego : Sharp Rees-Stealy Updated

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

San Diego : UCSD Moores Cancer Research Institute

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

San Diego : Sharp-Rees-Stealy Medical Group

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

San Diego : San Diego Pacific Oncology & Hematology Assoc Inc.

Phase 1 Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma

San Diego : Innovative Research Center of California

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

San Francisco : ImClone Investigational Site

A Study of IMC-CS4 in Subjects With Advanced Solid Tumors

San Francisco : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of LY2875358 in Patients With Advanced Cancer

San Francisco : UCSF

Bone Graft Materials Observational Registry

San Francisco : University of California San Francisco

ChemoFx® PRO - A Post-Market Data Collection Study

San Francisco : Investigational Site Number 840005

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

San Francisco : GSK Investigational Site

Dose-Escalation Study of GSK2126458

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

San Francisco : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

San Francisco : Research Site

Panitumumab Pediatric Study

San Francisco : Investigational Site Number 840001 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib

San Francisco : Investigational Site Number 840014 Updated

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

San Francisco : Call for Information (Investigational Site 0003)

Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)

San Jose : San Jose Women's Medical Group

ChemoFx® PRO - A Post-Market Data Collection Study

Santa Ana : Edward Alexson, MD, Inc.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Santa Barbara : 1200.75.10103 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Santa Barbara : 1200.75.10106 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Santa Barbara : Sansum Clinic

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Santa Barbara : Sansum Clinic

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Santa Barbara : Santa Barbara Hematology Oncology Medical Group, Inc.

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Santa Maria : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Santa Maria : 1200.75.10102 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Santa Maria : Central Coast Medical Oncology Corporation

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Santa Monica : Call for Information

A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)

Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Phase 1 Study of LY2835219 In Subjects With Advanced Cancer

Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of LY2875358 in Patients With Advanced Cancer

Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY3007113 in Patients With Advanced Cancer

Santa Monica : Premiere Oncology, A Medical Corporation Updated

A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies

Santa Monica : Southern California Medical Gastroenterology Group, Inc Updated

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Santa Monica : Santa Monica Research Institute

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Santa Monica : UCLA Hematology-Oncology Santa Monica

Phase 1 Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma

Santa Monica : UCLA Cancer Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Santa Monica : Sarcoma Oncology Center

Safety Study of Sterile Compound c31510 for Injection to Subjects With Solid Tumors

Santa Monica : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Santa Monica : Pfizer Investigational Site

Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Santa Monica : Premiere Oncology

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Santa Monica : UCLA Hematology-Oncology

Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors

Santa Monica :

Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors

Sherman Oaks : Women's Cancer Center Sherman Oaks

ChemoFx® PRO - A Post-Market Data Collection Study

Stanford : Stanford University School of Medicine

Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma

Stanford : Stanford University School of Medicine

Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer

Stanford : Stanford University School of Medicine

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Stanford : Stanford University School of Medicine

Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1

Stockton : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Sylmar : 1200.75.10107 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Tarzana : West Coast Clinical Research Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Torrance : GOA Torrance Memorial

ChemoFx® PRO - A Post-Market Data Collection Study

Torrance : Urology Specialists of Southern California - Torrance Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Torrance : Health Care Partners Medical Group

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Torrance : South Bay Gastroenterology Medical Group

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Valencia : UCLA Cancer Center-Valencia

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

West Covina : Wilshire Oncology Medical Group, Inc.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

West Hollywood : James R. Berenson MD, Incorporated

Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma

Westlake Village : UCLA Cancer Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Whittier : 1200.75.10039 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Yorba Linda : Southern California Oncology

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Aurora : University of Colorado

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Aurora : University of Colorado Cancer Center

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

Aurora : University of Colorado Hospital, Site #015

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113

Aurora : Rocky Mountain Cancer Centers

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Aurora : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

View More »

Aurora : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Aurora : Children's Hospital Colorado

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

Aurora :

Combination With Gemcitabine in Advanced Pancreatic Cancer

Aurora : University of Colorado Denver

Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors

Aurora : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Aurora : University of Colorado Health Science Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Aurora : University of Colorado Denver

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Aurora : Pfizer Investigational Site

Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Aurora : Research Site

Study to Assess Safety, Tolerability and PK of AZD1480 Alone or in Comb With Docetaxel in Patients With Solid Tumours

Aurora : University of Colorado Cancer Center Updated

Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors

Aurora :

Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors

Boulder : Rocky Mountain Cancer Centers

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Colorado Springs : Rocky Mountain Cancer Centers

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Denver : Rose Breast Center

A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers

Denver : Rocky Mountain Cancer Centers

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Denver : The Urology Center of Colorado

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Denver : The Urology Center of Colorado

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Denver : The Urology Center of Colorado

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Denver : The Urology Center of Colorado Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Denver : Genitourinary Surgical Consultants, PC Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Denver : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Denver : Rocky Mountain Cancer Centers - Denver Midtown

Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma

Denver : The Urology Center of Colorado

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Denver : Kaiser Permanente

Tracking Renal Tumors After Cryoablation Evaluation

Englewood : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Englewood : Urology Associates Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Fort Collins : Front Range Cancer Specialists

Dose-escalation Study of Oral CX-4945

Golden : Western Oncology/Hematology Associates, PC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lakewood : Rocky Mountain Cancer Centers

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Littleton : Rocky Mountain Cancer Centers

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lone Tree : Rocky Mountain Cancer Centers

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Longmont : Rocky Mountain Cancer Centers

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Loveland : Front Range Cancer Specialists

Dose-escalation Study of Oral CX-4945

Parker : Rocky Mountain Cancer Centers

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Pueblo : Rocky Mountain Cancer Centers

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Thornton : Rocky Mountain Cancer Centers

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Bridgeport : Gastroenterology Associates of Fairfield County

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Fairfield : Gastroenterology Associates of Fairfield County

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Farmington : University of Connecticut Health Center Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Middlebury : Connecticut Clinical Research Center, LLC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

New Britain : Grove Hill Medical Center Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

View More »

New Haven : Yale University Comprehensive Cancer Center

A Clinical Study of PHY906 as a Modulator of CPT-11 in Patients With Metastatic Colorectal Cancer

New Haven : Yale University, Site #033

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113

New Haven : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Head and Neck Cancer

New Haven : Yale Comprehensive Cancer Center

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

New Haven : Yale Comprehensive Cancer Center at Yale University School of Medicine

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

New Haven :

Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations

New Haven : Yale University, Comprehensive Cancer Center

Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers

New Haven :

Sorafenib Long Term Extension Program (STEP)

New Haven : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Norwalk : Norwalk Hospital

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Norwich : Eastern Connecticut Hematology and Oncology Associates

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Southington : 1200.75.10041 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Stamford : Medical Oncology Hematology, Stamford Hospital

MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

Torrington : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Waterbury : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Newark : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Newark : Christiana Hospital

Breath Test for Early Detection of Lung Cancer

Newark : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Aventura : South Florida Medical Research

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Aventura : Mount Sinai Comprehensive Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Aventura : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Boca Raton : South Florida Center for Gynecologic Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

Boynton Beach : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

View More »

Boynton Beach : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Boynton Beach : Visions Clinical Research

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Boynton Beach : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Boynton Beach : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Bradenton : Manatee Medical Research Institute, LLC

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Brooksville : Pasco Hernando Oncology Associates, P.A.

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Clearwater : West Coast Gynecologic Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

Coral Gables : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Coral Gables : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Delray Beach : Comprehensive Gynecologic Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

Fort Lauderdale : Holy Cross Hospital Bienes Comprehensive Cancer Center

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Fort Lauderdale : Caruso and Gates MDs PA

ChemoFx® PRO - A Post-Market Data Collection Study

Fort Myers : Florida Urology Physicians

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Fort Myers : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Fort Myers : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Fort Myers : Florida Cancer Specialists (Summerlin)

A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors

Fort Myers : Novartis Investigative Site Updated

Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors

Fort Myers : Florida Gynecologic Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

Fort Myers : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Fort Myers :

Dose Escalation Study of INK128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

Ft. Lauderdale : 1200.75.10028 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Ft. Myers : Florida Cancer Specialists

A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors

Hialeah : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Hialeah : Urological Research Network Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Holiday : 1200.75.10029 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Hudson : Florida Cancer Specialists, PL

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of LY2875358 in Patients With Advanced Cancer

Jacksonville : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Jacksonville : Mayo Clinic

Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia

Jacksonville : Mayo Clinic Florida

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Jacksonville : Investigational Site Number 840016 Updated

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Lake Worth : Altus Research

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Lake Worth : Medical Specialist of Palm Beaches

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Lakeland : Lakeland Regional Cancer Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Lakeland : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Melbourne : MIMA Century Research Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Miami : Advanced Medical Specialties

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Miami : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Miami : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Miami : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Miami : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Miami : Miami Research Associates Updated

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Miami : University of Miami Sylvester Comprehensive Cancer Center

Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors

Miami : Miami Research Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Miami : Advanced Pharma CR

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Miami Beach : Mount Sinai Comprehensive Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Miami Beach : Mount Sinai Comprehensive Cancer Center

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

New Port Richey : Florida Cancer Specialists, PL

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New Port Richey : Updated

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Ocala : Ocala Oncology Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Ocala : Ocala Oncology Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Ocala : Urology Health Team, PLLC Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Ocala : Ocala Oncology

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Orlando : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

Orlando : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Orlando : M.D. Anderson Cancer Center Orlando

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Orlando : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Orlando : MD Anderson Cancer Center

Breath Test for Early Detection of Lung Cancer

Pembroke Pines : Gynecologic Oncology Associates

ChemoFx® PRO - A Post-Market Data Collection Study

Plantation : 21st Century Oncology

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Plantation : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Port St. Lucie : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Sarasota : Florida Cancer Specialists

A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies

Sarasota : Call for Information (Investigational Site 0010)

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)

Sarasota : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Sarasota : Sarasota Memorial Hospital

ChemoFx® PRO - A Post-Market Data Collection Study

South Miami : South Miami Gynecologic Oncology Group

ChemoFx® PRO - A Post-Market Data Collection Study

South Miami : Miami Research Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

St. Petersberg : Pinellas Urology, Inc.

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Stuart : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Tampa : Research Site Updated

A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

Tampa : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Tampa : Call for Information (Investigational Site 0002)

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)

Tampa : Moffitt Cancer Center

Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors

Tampa : Moffitt Cancer Center & Research Institute Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Tampa : Novartis Investigative Site

MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations

Tampa : Moffitt Cancer Center Updated

Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C

Tampa : Updated

Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor BAY80-6946 With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms

Tampa : Moffitt Cancer Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Tampa : Call for Information (Investigational Site 0007)

Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)

Tampa : Moffitt Cancer Center

Study of KB004 in Subjects With Hematologic Malignancies

Tavares : 1200.75.10003 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Titusville : Space Coast Medical Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Trinity : Advanced Research Institute, Inc. Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

West Palm Beach : Palm Beach Cancer Institute

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

West Palm Beach : Palm Beach Cancer Institute

ChemoFx® PRO - A Post-Market Data Collection Study

West Palm Beach : Hal Bashein, DO Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Savannah : Memorial Health University Medical Center

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer COG ABTR01B1

View More »

Albany : Phoebe Putney Memorial Hospital

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Albany : Southwest Georgia Cancer Coalition

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Alpharetta : Georgia Cancer Specialists - Alpharetta

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Athens : Georgia Cancer Specialists - Athens

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Athens : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Atlanta : Emory Winship Cancer Institute

A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors

Atlanta : Emory University School of Medicine

A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors

Atlanta : Georgia Cancer Specialists - Emory Midtown

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Atlanta : Midtown Urology

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Atlanta : Peachtree Hematology-Oncology Consultants, PC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Atlanta : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Atlanta : Emory University

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Atlanta : Emory University, Winship Cancer Institute

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Atlanta : Emory University Winship Cancer Institute

A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer

Atlanta : St. Joseph's Hospital - Resurgeons Orthopedics

Bone Graft Materials Observational Registry

Atlanta : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Atlanta : Emory Crawford Long Hospital

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer

Atlanta : Grady Memorial Hospital

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer

Atlanta : Winship Cancer Institute of Emory University

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer

Atlanta : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Atlanta : Emory University Winship Cancer

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Atlanta : Atlanta Gastroenterology

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Atlanta : Atlanta Gastroenterology Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Atlanta : Emory University

Neoadjuvant Trial of Eribulin Followed by Dose Dense Doxorubicin and Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer

Atlanta : Emory University

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Atlanta : Emory University Winship Cancer Institute

Phase I Chemoprevention Trial With Green Tea Polyphenon E and Erlotinib in Patients With Premalignant Lesions of the Head and Neck

Atlanta : Emory University Winship Cancer Institute Updated

Re-expression of ER in Triple Negative Breast Cancers

Atlanta : Emory University

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Atlanta : Emory University

Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Atlanta : Emory University Winship Cancer Institute

Study of Arsenic Trioxide in Small Cell Lung Cancer

Atlanta : Emory University Winship Cancer Institute

Study of Everolimus (RAD001)in Combination With Lenalidomide

Atlanta : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Atlanta : Emory University Hospital

Study of MLN4924 in Adult Patients With Nonhematologic Malignancies

Atlanta : Winship Cancer Institute

Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma

Atlanta : Emory University Winship Cancer Institute

Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer

Atlanta : Emory University Winship Cancer Institute

Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores

Augusta : Augusta Oncology Associates, PC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Augusta : Investigational Site Number 1239

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Blakely : Primary Care of Southwest Georgia

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Columbus : John B. Amos Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Dawson : Albany Area Primary Health Care Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Decatur : Georgia Cancer Specialists - Stemmer

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Douglasville : Atlanta Gastroenterology Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Dublin : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Fayetteville : Georgia Cancer Specialists - Fayetteville

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Hiram : Atlanta Gastroenterology Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Lawrenceville : 1200.75.10105 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Macon : Georgia Cancer Specialists - Macon

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Macon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Marietta : Georgia Cancer Specialists - Kennestone

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Marietta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Marietta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Marietta : Urology Enterprises

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Marietta : Atlanta Gastroenterology Associates Updated

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Marietta : Atlanta Gastroenterology Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Newnan : Better Health Clinical Research Inc

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Riverdale : Southeastern Gynecologic Oncology, LLC

ChemoFx® PRO - A Post-Market Data Collection Study

Riverdale : Southern Regional Medical Center

Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis

Rome : Harbin Clinic

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Sandy Springs : Georgia Cancer Specialists - Northside

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Savannah : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Savannah : Memorial Health University Medical Center

ChemoFx® PRO - A Post-Market Data Collection Study

Stockbridge : Georgia Cancer Specialists - Stockbridge

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Stockbridge : Updated

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Valdosta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Honolulu : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Honolulu : The Queens' Medical Center

ChemoFx® PRO - A Post-Market Data Collection Study

Coeur d'Alene : North Idaho Urology

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Coeur d'Alene : Kootenai Cancer Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Post Falls : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Arlington Heights : NCH Medical Group

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Centralia : University Hematology Oncology, Inc.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Champaign : Christie Clinic

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Chicago :

A Dose-escalation Study in Subjects With Advanced Malignancies

Chicago : University of Chicago Medical Center, Site #001

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113

View More »

Chicago : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Chicago : Site Reference ID/Investigator# 23284 Updated

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

Chicago : Robert Lurie Comprehensive Cancer Center of Northwestern University

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Chicago : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Chicago :

A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Chicago : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Chicago : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Chicago : Site Reference ID/Investigator# 26525

ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors

Chicago : Center for Women

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Chicago : Rush University

ChemoFx® PRO - A Post-Market Data Collection Study

Chicago : Northwestern Medicine Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Chicago : University of Chicago Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Chicago : Northwestern Memorial Hospital Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Chicago : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Chicago : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Chicago : University of Illinois at Chicago

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Chicago : Jesse Brown VA

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Chicago : Rush University Gastroenterologists

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Chicago : Stroger Cook County

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Chicago : Jesse Brown VAMC

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Chicago : Northwestern University

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

Chicago : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Chicago :

Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors

Decatur : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Decatur : Investigational Site Number 840017 Updated

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Evanston : NorthShore Medical Group

ChemoFx® PRO - A Post-Market Data Collection Study

Evanston : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Galesburg : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Glenview : Uropartners

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Glenview : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Harvey : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer

Harvey : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Hines : VA Hospital

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Joliet : Joliet Oncology-Hematology Associates, Ltd.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Joliet : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Maywood : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Maywood : Loyola University, Cardinal Bernardin Cancer Center

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Maywood : Loyola University Medical Center

Umbilical Cord Transplantation for the Elderly Population

Melrose Park : Uropartners/RMD Clinical Research

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Melrose Park : UroPartners/RMD Clinical Research

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Melrose Park : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Naperville : DuPage Medical Group

Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer

Niles : Oncology Specialists, S.C.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Niles : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Oak Lawn : Southwest Gastroenterology

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Park Ridge : Oncology Specialists, S.C.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Peoria : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Quincy : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Rockford : Rockford Gastroenterology Associates, LTD

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Skokie : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Skokie : 1200.75.10031 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Springfield :

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Springfield : Southern Illinois University School of Medicine

A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors

Urbana : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Zion : Midwestern Regional Medical Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Anderson : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Avon : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Carmel : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Evansville : Deaconess Clinic, Inc. Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Evansville : Global Scientific Innovations

NP2 Enkephalin For Treatment of Intractable Cancer Pain

View More »

Fishers : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Fort Wayne : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Greenfield : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors

Indianapolis : Indiana University Cancer Center

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

Indianapolis : Indiana University Simon Cancer Center

A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer

Indianapolis : ImClone Investigational Site

A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors

Indianapolis : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Indianapolis : Indiana University

ChemoFx® PRO - A Post-Market Data Collection Study

Indianapolis :

Dose Escalation Study of INK128 in Subjects With Advanced Cancer

Indianapolis : Community Regional Cancer Center-Community Hospital North

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

Indianapolis : Quality Oncology Care, Inc.

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

Indianapolis : Roudebush VA Medical Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Indianapolis : IUPUI

Phase 1 Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma

Indianapolis : St. Francis Medical Group Oncology and Hematology Specialists

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Indianapolis : Indiana University Cancer Center

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors

Indianapolis : Indiana University Simon Cancer Center Updated

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors

Indianapolis : Indiana University Simon Cancer Center

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Jeffersonville : Metropolitan Urology Clinical Research

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Jeffersonville : Metropolitan Urology Clinical Research

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Jeffersonville : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Lafayette : Horizon Oncology Center

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Lafayette :

Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors

Lafayette : Horizon Oncology Research, Inc.

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Martinsville : Morgan Hospital and Medical Center

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

New Albany : 1200.75.10025 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Terre Haute : 1200.75.10108 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Ames : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Ames : McFarland Clinic

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Cedar Rapids : Physician's Clinic of Iowa, P.C.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Cedar Rapids : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Cedar Rapids : Iowa Blood and Cancer Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

View More »

Clive : Iowa Digestive Disease Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Des Moines : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Iowa City : University of Iowa Hospitals and Clinics

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Iowa City : University of Iowa Hospitals and Clinics

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Iowa City : Holden Comprehensive Cancer Center

Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer

Sioux City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Sioux City : Siouxland Hematology Oncology Associates

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Waterloo : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Waterloo : 1200.75.10020 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

West Desmoines :

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Fairway : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Kansas City :

A Study of RO5045337 in Patients With Solid Tumors

Kansas City : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Kansas City : University of Kansas Medical Center

Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers

Overland Park : Kansas City Urology Care, P.A. Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

View More »

Westwood : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Wichita : Cancer Center of Kansas

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Wichita : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Wichita : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Wichita : Cancer Center of Kansas

Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers

Wichita : GSK Investigational Site

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Hazard : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Lexington : University of Kentucky

Tracking Renal Tumors After Cryoablation Evaluation

Louisville : Owlsey Brown Frazier Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Louisville : James Graham Brown Cancer Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Louisville : University of Louisville James Brown Cancer Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

View More »

Paducah : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Paducah : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Paducah : Investigational Site Number 840003 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Paducah : Investigational Site Number 840002 Updated

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Alexandria : Hematology Oncology Life Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Bastrop : Gastroenterology & Nutritional Medical Services

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Bastrop : Morehouse General Hospital

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Baton Rouge : Gastroenterology Associates

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Baton Rouge : Gastroenterology Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

View More »

Baton Rouge : Investigational Site Number 840013 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Covington : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Covington : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Covington : Women's Cancer Center

ChemoFx® PRO - A Post-Market Data Collection Study

Metairie : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Metairie : New Orleans Research Institue Updated

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Metairie : New Orleans Research Institute

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Metairie : Investigational Site Number 840003 Updated

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Monroe : Delta Research Partners, LLC

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

New Orleans : Tulane University Health Sciences Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New Orleans : Ochsner Clinic Foundation

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

New Orleans : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

New Orleans : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

New Orleans : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

New Orleans : 1200.75.10019 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

New Orleans : Tulane University Medical School

Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer

New Orleans :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Shreveport : Regional Urology

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Shreveport : CHRISTUS Schumpert Health System

ChemoFx® PRO - A Post-Market Data Collection Study

Shreveport : Louisiana Research Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Shreveport : Pfizer Investigational Site

Open Label Extension In Cancer Patients

Lewiston : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Scarborough : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Baltimore :

A Dose-escalation Study in Subjects With Advanced Malignancies

Baltimore : Research Site

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Baltimore : Site Reference ID/Investigator# 54056

A Study of ABT-806 in Subjects With Advanced Solid Tumor Types

Baltimore : University of MD Greenbaum Cancer Center

A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors

Baltimore : Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

A Study of of MORAb-004 in Subjects With Solid Tumors

View More »

Baltimore : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Baltimore : The Sidney Kimmel Comprehensive Cancer Center

A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Advanced Prostate Cancer

Baltimore : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

Baltimore : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Baltimore : Sinai Hospital

ChemoFx® PRO - A Post-Market Data Collection Study

Baltimore : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Dose-Escalation Phase 1 Study of G-202 in Patients With Advanced Solid Tumors

Baltimore : University of Maryland Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Baltimore : Chesapeake Urology Research Associates Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Baltimore : University of Maryland & Baltimore VA medical centre

Low Dose Radiation Therapy as Chemosensitizer in GI/ Ovarian Tumors

Baltimore : Digestive Disease Associates, PA

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Baltimore : University of Maryland Greenebaum Cancer Center

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

Baltimore : Investigational Site Number 840019 Updated

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Safety Study of Live Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib and GSK1120212 in Advanced Solid Tumors Enriched With Patients With Advanced Differentiated Thyroid Cancer

Baltimore :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Baltimore : Weinberg Cancer Institution at Franklin Square

Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors

Baltimore : Saint Agnes Healthcare

Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Bethesda : National Cancer Institute - Center for Cancer Research

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Bethesda : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Bethesda : 1200.75.10038 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Bethesda : Center for Cancer and Blood Disorders

Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma

Bethesda : NCI, CCR

Open Label Study to Evaluate the Safety and Tolerability of GI-6301 a Vaccine Consisting of Whole Heat-Killed Recombitant Yeast Genetically Modified to Express Brachyury Protein in Adults With Solid Tumors

Bethesda : National Cancer Institute Center for Cancer Research, Medical Oncology Branch

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Bethesda : Bethesda Naval Medical Center

The Study of Barrett's Esophagus: What Are the Factors of Progression

Chevy Chase : Chevy Chase Clinical Research

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Chevy Chase : Metropolitan Gastroenterology Group

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Columbia : Columbia Medical Practice Updated

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Columbia : Columbia Medical Practice

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Cumberland : Corbin Clinical Resources Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Elkridge : Centennial Medical Group

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Frederick : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Glen Burnie : Chesapeake Urology Research Associates Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Greenbelt : Myron I Murdock MD LLC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Greenbelt : Myron I. Murdock MD, LLC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Greenbelt : Myron I. Murdock, MD, LLC

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Greenbelt : Myron I. Murdock, MD, LLC Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Kensignton :

A Study of RO5045337 in Patients With Solid Tumors

Rockville : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Salisbury : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Silver Springs : Women's Health Specialists

ChemoFx® PRO - A Post-Market Data Collection Study

Towson : Chesapeake Urology Research Associates Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Boston : Massachusetts General Hospital Cancer Center

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Boston : Call for Information

A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)

Boston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician

A Phase 1 Study of LY2835219 In Subjects With Advanced Cancer

Boston : Mass General Hospital (MGH), Site #047

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113

Boston : Beth Israel Deaconess Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

View More »

Boston : Dana Farber Cancer Institute

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Boston : Novartis Investigative Site

A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors

Boston : Dana Farber Cancer Institute

A Safety Study of Oral ZSTK474 in Patients With Cancer

Boston : Site Reference ID/Investigator# 41931

A Study of ABT-806 in Subjects With Advanced Solid Tumor Types

Boston : Research Site

A Study of AMG 337 in Subjects With Advanced Solid Tumors

Boston : ImClone Investigational Site

A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors

Boston : Dana Farber Cancer Institute (DFCI)

A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors

Boston : Beth Israel Deaconess Medical Center (BIDMC)

A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors

Boston : Novartis Investigative Site

A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors

Boston : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Boston : Dana Farber Cancer Institute

A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors

Boston :

A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Boston : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Boston : Tufts-New England Medical Center

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

Boston : Novartis Investigative Site

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma

Boston : BWH

An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

Boston : Site Reference ID/Investigator# 58882

An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors

Boston : Dana-Farber Cancer Inst

Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers

Boston : Beth Israel Deaconess Medical Center`

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Boston : Dana-Farber Cancer Institute

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Boston : Massachusetts General Hospital

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Boston :

Dose Escalation Study of INK128 in Subjects With Advanced Cancer

Boston : Massachusetts General Hospital / Dana Farber Cancer Institute

E7050 in Combination With E7080 in Subjects With Advanced Solid Tumors (Dose Escalation) and in Subjects With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)

Boston : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Boston : Beth Israel Deaconess Medical Center

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

Boston : Dana-Farber Cancer Institute

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

Boston : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Boston : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Boston : Beth Israel Deaconess Medical Center

MSC2015103B in Solid Tumors

Boston : Dana-Farber Cancer Institute

MSC2015103B in Solid Tumors

Boston : Boston Medical Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Boston : Investigational Site Number 840002

Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors

Boston : Investigational Site Number 840001

Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors

Boston : Beth Israel Deaconess Medical Center

Pazopanib and Everolimus in Patients With Advanced Solid Tumors and Previously Treated Kidney Cancer

Boston : Dana-Farber Cancer Institute

Pazopanib and Everolimus in Patients With Advanced Solid Tumors and Previously Treated Kidney Cancer

Boston : Dana-Farber Cancer Institute

Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Boston : Investigational Site Number 840012 Updated

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Boston : Dana-Farber Cancer Institute

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Boston : Beth Israel Deaconess Medical Center

Safety Study of PLX108-01 in Patients With Solid Tumors

Boston : Dana Farber Cancer Institute

Safety Study of PLX108-01 in Patients With Solid Tumors

Boston : Massachusetts General Hospital

Safety Study of PLX108-01 in Patients With Solid Tumors

Boston : Novartis Investigative Site

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

Boston : Novartis Investigative Site

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

Boston : Dana Farber Cancer Institute

Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer

Boston : Beth Israel Deaconess Medical Center

Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors

Boston : Dana Farber Cancer Institute

Study of PWT33597 Mesylate in Subjects With Advanced Malignancies

Boston : Beth Israel Deaconess Medical Center (BIDMC) - Cancer Center

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Boston : Massachusetts General Hospital Cancer Center

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Boston : Dana Farber Cancer Institute

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Boston : Investigational Site Number 1133

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Boston : Dana Farber Cancer Institute

Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors

Boston : Massachusetts General Hospital

Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors

Boston : Massachusetts General Hospital

Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

Boston : Dana Farber Cancer Institute

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Brockton : Commonwealth Clinical Studies

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Brockton : Commonwealth Clinical Studies PLLC

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

East Bridgewater : Commonwealth Clinical Studies PLLC

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Rockland : For Recruiting Locations in the US contact US Medical Information in

Combination Trial MSC1936369B With Temsirolimus

Watertown : Bay State Urologists Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Worcester : UMass Memorial Hospital

ChemoFx® PRO - A Post-Market Data Collection Study

Ann Arbor : University of Michigan Comprehensive Cancer Center

A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors

Ann Arbor : University of Michigan Comprehensive Cancer Center

A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors

Ann Arbor : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Ann Arbor : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of LY2875358 in Patients With Advanced Cancer

Ann Arbor : University of Michigan Comprehensive Cancer Center

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

View More »

Ann Arbor : University of Michigan Cancer Center

Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas

Ann Arbor : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Ann Arbor : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Ann Arbor : University of Michigan

Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone

Dearborn : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Detriot : Wayne State University Karmanos Cancer Institute

Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies

Detroit : Karmanos Cancer Institute

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Detroit : Karmanos Cancer Institute

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

Detroit :

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Detroit : Karmanos Cancer Institute

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Detroit : Site Reference ID/Investigator# 19021

A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases

Detroit : Karmanos Cancer Institute

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Detroit :

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma

Detroit : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Detroit : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Detroit : Research Site

A Study of AMG 337 in Subjects With Advanced Solid Tumors

Detroit : Henry Ford Health System

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Detroit : Wayne State University Department of Oncology Karmanos Cancer Institute

A Study of DS-2248, in Subjects With Advanced Solid Tumors

Detroit : Novartis Investigative Site

A Study of Oral LGK974 in Patients With Melanoma and Lobular Breast Cancer

Detroit : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Detroit : Karmanos Cancer Institute

A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor

Detroit : Karmanos Cancer institute

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

Detroit : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

Detroit : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Detroit : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Detroit : Site Reference ID/Investigator# 62482

An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors

Detroit : Wayne State University

Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers

Detroit : Henry Ford Health System

ChemoFx® PRO - A Post-Market Data Collection Study

Detroit : Karmanos Cancer Institute

ChemoFx® PRO - A Post-Market Data Collection Study

Detroit : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Detroit : Wayne State University, Division of Hematology/Oncology, Karmanos Cancer Institute

Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors

Detroit : Henry Ford Medical Center

E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer

Detroit : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Detroit : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Detroit : Karmanos Cancer Institute

MSC2015103B in Solid Tumors

Detroit : Karmanos Cancer Institute

Oral Azacitidine as a Single Agent and in Combination With Carboplatin or Abraxane® in Subjects With Relapsed or Refractory Solid Tumors

Detroit : Karmanos Cancer Institute

Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer

Detroit : Henry Ford Health System

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Detroit : Wayne State (Karmanos Cancer Institute)

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Detroit : Karmanos Cancer Institute

Safety Study of AB0024 in Patients With Advanced Solid Tumors

Detroit : Novartis Investigative Site

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

Detroit : Site Reference ID/Investigator# 57555

Study of ABT-700 in Subjects With Advanced Solid Tumors

Detroit : Karmanos Cancer Institute

Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)

Detroit : Karmanos Cancer Institute

Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors

Detroit : Karmanos Cancer Institute

Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

Detroit : Karmanos Cancer Institute

Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors

Detroit : Wayne State University/Karmanos Cancer Institute

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Detroit : Investigational Site Number 1326

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Detroit : Research Site

Study to Assess Safety, Tolerability and PK of AZD1480 Alone or in Comb With Docetaxel in Patients With Solid Tumours

Detroit : Karmanos Cancer Center

Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors

Detroit : Henry Ford Health System Protocol Review Committee Updated

Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors

Farmington Hills : Karmanos Cancer Institute at Farmington Hills

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Grand Rapids : Spectrum Health Medical Group

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Grand Rapids : Gynecologic Oncology of West Michigan

ChemoFx® PRO - A Post-Market Data Collection Study

Grand Rapids : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Lansing : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Southfield : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Southfield : PRESSD

Bone Graft Materials Observational Registry

St. Clair Shores : Michgan Institute of Urology, PC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Troy : Michigan Institute of Urology, PC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Troy : Center for Digestive Health

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Utica : Michigan Institute of Urology, PC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Warren : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Burnsville : Minnesota Oncology Hematology, P.A.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Coon Rapids : Minnesota Oncology Hematology, P.A.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Duluth : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Duluth : 1200.75.10005 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Edina : Minnesota Oncology Hematology, P.A.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View More »

Fridley : Minnesota Oncology Hematology, P.A.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Maplewood : Minnesota Oncology Hematology, P.A.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Minneapolis : Minnesota Oncology Hematology, P.A.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Minneapolis : Research Site

Panitumumab Pediatric Study

Minneapolis : University of Minnesota Medical Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Minneapolis : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Minneapolis : University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Rochester : Mayo Clinic Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Rochester : Call for Information (Investigational Site 0001)

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)

Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 in Patients With Advanced Cancer

Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of LY2875358 in Patients With Advanced Cancer

Rochester : Mayo Clinic

Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas

Rochester : Mayo Clinic

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Rochester : Mayo Clinic Rochester

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Rochester : Updated

Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor BAY80-6946 With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

Rochester : Mayo Clinic Cancer Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Rochester : Investigational Site Number 840008 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Rochester : Mayo Clinic

Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence

Rochester : Pfizer Investigational Site

Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors

Rochester : Investigational Site Number 840007 Updated

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Saint Cloud : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

St Louis Park : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

St. Louis Park : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

St. Paul : Minnesota Oncology Hematology, P.A.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Woodbury : Minnesota Oncology Hematology, P.A.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Jackson : Mississippi Oncology Associates

ChemoFx® PRO - A Post-Market Data Collection Study

Southaven : University of Tennessee Cancer Institute

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Columbia : Investigational Site Number 840015 Updated

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Kansas City : Research Medical Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Kansas City : Department of Veterans Affairs Medical Center

The Study of Barrett's Esophagus: What Are the Factors of Progression

Saint Louis : Research Site

A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors

Saint Louis : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

View More »

Saint Louis : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Springfield : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

St Louis : Washington University

A Safety Study of Oral ZSTK474 in Patients With Cancer

St Louis : Washington University Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

St Louis : Investigational Site Number 840001 Updated

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

St. Louis : Siteman Cancer Center, Washington University School of Medicine

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

St. Louis :

Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer

St. Louis :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

St. Louis : Washington University School of Medicine Updated

Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors

Billings : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Billings : Billings Clinic Cancer Center

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Billings : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Great Falls : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Missoula : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

View More »

Missoula : Montana Neuroscience Institute Foundation

Bone Graft Materials Observational Registry

Missoula : Montana Cancer Institute Foundation

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Lincoln : Southeast Nebraska Hematology & Oncology Consultants, PC / Southeast Nebraska Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lincoln : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Omaha : Urology Cancer Center and GU Research Network

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Omaha : GU Research Network, LLC

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Omaha : Urology Cancer Center & GU Research Network

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View More »

Omaha : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Omaha : Nebraska Methodist Hospital

Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors

Omaha : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Omaha : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Omaha : University of Nebraska

Tracking Renal Tumors After Cryoablation Evaluation

Henderson : Comprehensive Cancer Centers of Nevada

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Henderson : Comprehensive Cancer Centers of Nevada

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Las Vegas : Comprehensive Cancer Centers of Nevada

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Las Vegas : Comprehensive Cancer Centers of Nevada

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

View More »

Las Vegas : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Las Vegas : Comprehensive Cancer Centers of Nevada

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Las Vegas : Comprehensive Cancer Centers of Nevada

Safety Study of PLX108-01 in Patients With Solid Tumors

Las Vegas : Comprehensive Cancer Centers of Nevada

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Las Vegas :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Reno : VA Sierra Nevada HealthCare System

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Reno : Digestive Health Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Reno : Advanced Research Institute

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Reno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study in Head and Neck Cancer

Dover : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Lebanon : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Lebanon : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Berkeley Heights : Summit Medical Group

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Berlin : Updated

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Denville : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Egg Harbor Township : AGA Clinical Research Associates, LLC

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Hackensack : Research Site

AMG 319 Lymphoid Malignancy FIH

View More »

Hackensack : Hackensack University Medical Center

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Hackensack : Haceknasack University Medical Center

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

Hackensack : Cancer Center at Hackensack University Medical Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Lawrenceville : Premier Urology Associates, LLC / AdvanceMed Research

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Morristown : Hematology-Oncology Associates of Northern NJ, PA; Carol G. Simon Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Morristown : Morristown Memorial Hospital

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Mt. Laurel : Delaware Valley Urology, LLC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Mt. Laurel : Delaware Valley Urology, LLC Burlington Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

New Brunswick :

Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations

New Brunswick : Cancer Institute of New Jersey

Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors

New Brunswick : GSK Investigational Site

Dose-Escalation Study of GSK2126458

New Brunswick : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

New Brunswick : The Cancer Institute of New Jersey

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

New Brunswick : Cancer Institute of New Jersey

Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors

Newark : Investigational Site Number 840009 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Newark : Investigational Site Number 840006 Updated

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Princeton : Bracco Diagnostics Inc.

SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization

Princeton : Bracco Diagnostics Inc

SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization

Somerville : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Teaneck : Holy Name Medical Center

An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

Teaneck : Gara M Sommers MD

ChemoFx® PRO - A Post-Market Data Collection Study

Teaneck : 1200.75.10002 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Voorhees : Cooper Health System

ChemoFx® PRO - A Post-Market Data Collection Study

Vorhees : Delaware Valley Urology Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Albuquerque : Research Site

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Albuquerque : New Mexico Oncology Hematology Consultants, LTD

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Albuquerque : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Santa Fe : New Mexico Cancer Care Associates

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Albany : New York Oncology Hematology, P.C.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Albany : Women's Cancer Care Associates

ChemoFx® PRO - A Post-Market Data Collection Study

Albany : The Capital Region Medical Research Foundation, Inc. Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Albany : Albany Medical Center Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Albany : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

View More »

Albany : NYOH Albany Cancer Center at Patroon Creek

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Albany : Community Care Physicians, PC

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Atlantic Beach : St. John's Episcopal Hospital

ChemoFx® PRO - A Post-Market Data Collection Study

Binghamton : Binghamton Gastroenterology

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Bronx : Albert Einstein Cancer Center at the Montefiore Medical Park

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Bronx : Montefiore Medical Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Bronx : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Bronx : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Bronx : Montefiore Medical Center

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Bronx : Novartis Investigative Site Updated

Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors

Bronx : Montefiore Medical Center

ChemoFx® PRO - A Post-Market Data Collection Study

Bronx : Montefiore Medical Center Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Bronx : Eastchester Center for Cancer Care

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Bronx : Montefiore Medical Center

Safety Study of Live Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy

Bronx : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Brooklyn : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Buffalo : Zale P. Bernstein, MD, PC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Buffalo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Buffalo : Roswell Park Cancer Institute

ChemoFx® PRO - A Post-Market Data Collection Study

Buffalo : Roswell Park Cancer Institute

Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors or Advanced Pancreatic Cancer

Buffalo : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Buffalo :

Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors

Buffalo : Roswell Park Cancer Institute

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Buffalo : Roswell Park Cancer Institute

Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies

East Setaukey : North Shore Hematology/Oncology Associates

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

East Syracuse : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Garden City : Accumed Research Associates Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Garden City : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Great Neck : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Great Neck : Long Island Gastrointestinal Group

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Great Neck : Gastrointestinal Research Group

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Great Neck : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Lake Success : Monter Cancer Center

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Lake Success : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Lake Success : 1200.75.10044 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Lake Success : North Shore University Hospital-Monter Cancer Center

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Manhasset : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Manhasset : North Shore University Hospital

Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors

Manhassett : North Shore LIJ Health System

ChemoFx® PRO - A Post-Market Data Collection Study

New Hyde Park : North Shore University Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

New York : Call for Information

A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)

New York : Novartis Investigative Site

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Dose-Escalation Study in Participants With Advanced Cancer

New York : Memorial Sloan-Kettering Cancer Center

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

New York : Columbia University Medical Center

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

New York : University Urology Associates

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

New York : NYU Langone Medical Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New York : NYU Clinical Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New York : University Urology Associates

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New York :

A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

New York : Site Reference ID/Investigator# 23282 Updated

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

New York : Memorial Sloan Kettering Cancer Center

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

New York : Weill Cornell Cancer Center

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

New York : Memorial Sloan-Kettering Cancer Center

A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours

New York : Memorial Sloan Kettering Cancer Center

A Study of of MORAb-004 in Subjects With Solid Tumors

New York :

A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

New York : Memorial Sloan Kettering Cancer Center

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

New York : Memorial Sloan Kettering Cancer Center

A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Advanced Prostate Cancer

New York : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

New York : Novartis Investigative Site

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma

New York : New York Downtown Hospital

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

New York : Mount Sinai

An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

New York : Memorial Sloan Kettering Cancer Center

BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors

New York : New York University Medical Center

Breath Test for Early Detection of Lung Cancer

New York : Memorial Sloan-Kettering Cancer Center

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

New York : The Mount Sinai Medical Center

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

New York : Columbia University Medical Center Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

New York : University Urology Associates Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

New York : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

New York :

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

New York : 1200.75.10008 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

New York : 1200.75.10027 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

New York : Mount Sinai School of Medicine

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

New York : Alpert Pavilion

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

New York : Faculty Practice Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

New York : GI Clinic

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

New York : Internal Medicine Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

New York : Mount Sinai School of Medicine

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

New York : Practice Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

New York : Research Site

Panitumumab Pediatric Study

New York : Memorial Sloan-Kettering Cancer Center

Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors

New York : Mount Sinai Medical Center

Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors

New York : Memorial Sloan Kettering Cancer Center

Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence

New York : NYU Cancer Center

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

New York : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

New York : Memorial Sloan-Kettering Cancer Center

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors

New York : Research Site

Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours

New York :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

New York : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

New York : Memorial Sloan-Kettering Cancer Center

Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer

New York : Memorial Sloan-Kettering Cancer Center

Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors

New York : Memorial Sloan-Kettering Cancer Center

Tesetaxel as First-line Therapy for Metastatic Breast Cancer

New York : Columbia University

Tracking Renal Tumors After Cryoablation Evaluation

New York city : Department of Radiation oncology, Memorial Sloan Kettering Cancer Center

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

Port Jefferson : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Poughkeepsie : Hudson Valley Urology, P.C.

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Poughkeepsie : Premier Medical Group of the Hudson Valley

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Poughkeepsie : Premier Medical Group of the Hudson Valley Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Poughkeepsie : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Poughkeepsie : Premier Medical Group of the Hudson Valley

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Rochester : University of Rochester Medical Center, James P. Wilmot Cancer Center

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Rochester : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Staten Island : Staten Island Urological Research, PC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Staten Island : Staten Island Urological Research, PC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Staten Island : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Staten Island : Richmond University Medical Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Stony Brook : Research Site

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders

Syracuse : Associated Medical Professionals of New York, PLLC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Syracuse : Syracuse Orthopedic Specialists

Bone Graft Materials Observational Registry

Advance : Digestive Health Specialists, PA

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Asheville : Hope: A Women's Cancer Center

ChemoFx® PRO - A Post-Market Data Collection Study

Asheville : 1200.75.10110 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Asheville : Asheville Gastroenterology

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Asheville : Asheville Gastroenterology Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

View More »

Asheville : Cancer Care of WNC

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Asheville : Allergy Partners of West North Carolina

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Boone : MediSpect

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Burlington : Alamance Regional Cancer Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Cary : Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Cary : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Chapel Hill : Novartis Investigative Site

A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors

Chapel Hill : University of North Carolina - Chapel Hill

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Chapel Hill : GSK Investigational Site

Dose-Escalation Study of GSK2126458

Chapel Hill : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Chapel Hill : UNC - Chapel Hill

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Chapel Hill : Updated

Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor BAY80-6946 With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

Chapel Hill : University of North Carolina

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Chapel Hill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study in Head and Neck Cancer

Chapel Hill : Lineberger Comprehensive Cancer Center, University of North Carolina

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer

Chapell Hill : University of North Carolina at Chapel Hill

E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer

Charlotte : Presbyterian Hospital Center for Cancer Research

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Charlotte : Blumenthal Cancer Center - Main

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Charlotte : Carolinas Medical Center

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Charlotte : Carolinas Hematology-Oncology Associates

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Charlotte : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Charlotte : Blumenthal Cancer Center

ChemoFx® PRO - A Post-Market Data Collection Study

Charlotte : Presbyterian Gynecologic Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

Charlotte : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Charlotte : Carolina Digestive Endoscopy Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Charlotte : Carolina Digestive Health Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Charlotte : Carolinas HealthCare System

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Concord : Northeast Urology Research

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Concord : Carolinas Medical Center- North East

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Concord : Gateway Surgery Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Concord : Carolina Digestive Health Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Davidson : Carolina Digestive Health Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Durham : Research Site

A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumor

Durham : Regional Cancer Care PA

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Durham : Duke University Medical Center - Duke South Clinics

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Durham : Regional Cancer Care, P.A.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Durham : Duke University Medical Center

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Durham : Research Site

AMG 319 Lymphoid Malignancy FIH

Durham : Novartis Investigative Site

Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors

Durham : Duke University Medical Center

ChemoFx® PRO - A Post-Market Data Collection Study

Durham : Duke University Medical Center

Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors

Durham : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Durham : Duke Cancer Institute

Dose Escalation Study of Pazopanib Plus TH-302

Durham : Duke University Medical Center

Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas

Durham : Pediatric Bone and Cord Blood, Duke Univ. Med. Center

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Durham : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Durham :

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

Durham : Duke University Medical Center

Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma

Durham : Duke University Medical Center

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Durham : Duke University Medical Center

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Durham : Duke University Medical Center

Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors

Durham : Site Reference ID/Investigator# 66111

Study of ABT-700 in Subjects With Advanced Solid Tumors

Durham : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Durham : Duke University Medical Center Pediatric Blood and Marrow Transplant

Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies

Fayetteville : Cape Fear Valley Health System

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fayetteville : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Fayetteville : Cumberland Research Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Gastonia : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Goldsboro : Southeast Medical Oncology Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Goldsboro : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Greensboro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Greensboro : Alliance Urology Specialists, PA

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Greensboro : The Moses Cone Regional Cancer Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Greenville : Leo W. Jenkins Cancer Center at ECU Medical School

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Harrisburg : Carolina Digestive Health Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

High Point : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Huntersville : Carolina BioOncology Institute, PLLC

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Huntersville : Carolina Digestive Endoscopy Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Kernersville : Digestive Health Specialists, PA

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

New Bern : Coastal Carolina Health Care, PA, dba New Bern Cancer Care

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New Bern : New Bern Cancer Care, PA

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Pinehurst, : First Health of the Carolinas, Moore Regional Hospital

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Raleigh : Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Raleigh : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Raleigh : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Raleigh : Wake Research Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Raleigh : Rex Cancer Center at Rex Hospital

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Raleigh :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Washington : Marion L. Shepard Cancer Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Wilmington : North Hanover Regional Medical Center

ChemoFx® PRO - A Post-Market Data Collection Study

Wilmington : Hanover Medical Specialists

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Wilmington : New Hanover Regional Medical Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Wilmington : Wilmington Gastroenterology Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Winston Salem : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

Winston Salem : University of Wake Forest Baptist Medical Center

Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma

Winston-Salem : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Winston-Salem : Digestive Health Specialists, PA

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Winston-Salem : Center for Clinical Research

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Winston-Salem : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Bismarck : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

Bismarck : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Fargo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Fargo : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Akron : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Canton : Gabrail Cancer Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Canton : 1200.75.10021 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Canton : Gabrail Cancer Center Research LLC

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Canton : Investigational Site Number 840002 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

View More »

Cincinnati : TriState Urologic Services PSC, Inc. dba TUG Research

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Cincinnati : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Cincinnati :

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Cincinnati : University of Cincinnati

ChemoFx® PRO - A Post-Market Data Collection Study

Cincinnati : Investigational Site Number 840004

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

Cincinnati : TriState Urologic Services PSC, Inc. Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Cincinnati : Investigational Site Number 840002

First in Man Study of SAR566658 Administered Every 3 Weeks in Patients With DS6-positive and Refractory Solid Tumors

Cincinnati : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Cincinnati : 1200.75.10023 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Cincinnati : Investigational Site Number 840007 Updated

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Cincinnati :

Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors

Cinncinati :

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

Cleveland : Research Site

A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumor

Cleveland : ImClone Investigational Site

A Study of IMC-CS4 in Subjects With Advanced Solid Tumors

Cleveland : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Cleveland : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Cleveland : Case Western Reserve University, University Hospitals of Cleveland

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Cleveland : Cleveland Clinic, Taussig Cancer Institute

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Cleveland : University Hospitals of Cleveland

Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

Cleveland :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Cleveland : Cleveland Clinic

The Study of Barrett's Esophagus: What Are the Factors of Progression

Columbus : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

Columbus : Columbus Urology Research

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Columbus : ImClone Investigational Site

A Study of IMC-CS4 in Subjects With Advanced Solid Tumors

Columbus : Columbus Urology Research, LLC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Columbus : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Columbus : OSU Gynecologic Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

Columbus : Columbus Urology Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Columbus : Ohio State University Comprehensive Cancer Center - The James

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

Columbus : The Ohio State University - Comprehensive Cancer Center

Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma

Columbus : Investigational Site Number 1325

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Columbus : Ohio State University

Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Englewood : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Kettering : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Middletown : Signal Point Clinical research Center

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Middletown : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Toedo : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Bethany : Parkhurst Research Organization, LLC Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Oklahoma City : University of Oklahoma

A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors

Oklahoma City : University of Oklahoma Health Sciences Center

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Oklahoma City : Oklahoma University

A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors

Oklahoma city : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

View More »

Oklahoma City : Oklahoma University

A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Oklahoma City : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Oklahoma City : Novartis Investigative Site Updated

Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors

Oklahoma City : Oklahoma Gynecologic Oncology Group

ChemoFx® PRO - A Post-Market Data Collection Study

Oklahoma City :

Dose Escalation Study of INK128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Notch Inhibitor in Advanced Cancer

Oklahoma City : Peggy and Charles Stephenson Oklahoma Cancer Center

Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers

Oklahoma City : Oklahoma University Cancer Institute

Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors

Oklahoma City : Peggy and Charles Stephens Oklahoma Cancer Center

Safety Study of X-82 in Patients With Advanced Solid Tumors

Oklahoma City : Oklahoma University

Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors

Oklahoma City : Investigational Site Number 1434

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Oklahoma City : Univ. Oklahoma Health Science Center

Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors

Bend : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Eugene : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Eugene : Pain Research of Oregon

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Portland : Northwest Cancer Specialists, P.C.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Portland : Providence Cancer Center Oncology and Hematology Care

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View More »

Portland : Providence Portland Cancer Center

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Portland : Oregon Health & Science University

Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy

Portland : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Portland : Oregon Health & Science University

ChemoFx® PRO - A Post-Market Data Collection Study

Portland : Providence Cancer Center Oncology and Hematology Care

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Portland : Novartis Investigative Site

MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations

Portland : Northwest Gastroenterology Clinic, LLC

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Portland : Northwest Gastroenterology Clinic, LLC

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Portland : Research Site

Panitumumab Pediatric Study

Portland : Oregon Health & Science University

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Portland : Oregon Health and Sciences University

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas

Portland : Providence Cancer Center

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas

Portland : Providence Portland Med Ctr

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors

Portland : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Portland : Oregon Health and Science University

Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

Springfield : Willamette Valley Cancer Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Tualatin : Northwest Cancer Specialists, P.C.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Tualatin : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Tualatin : Legacy Meridian Park Medical Center Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Abington : Call for Information (Investigational Site 0009)

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)

Abington : Investigational Site Number 1132

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Allentown : Breast Care Specialist, PC

Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer

Bala Cynwyd : Urologic Consultants of SE PA

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Bala Cynwyd : Urology Consultants of Southeastern Pennsylvania

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

View More »

Bala Cynwyd : Urologic Consultants of SE PA Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Bethlehem : Investigational Site Number 840010 Updated

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Bryn Mawr : Urology Health Specialists, LLC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Bryn Mawr : Urology Health Specialists, LLC Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Carnegie : GSK Investigational Site

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Danville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Indiana : Ilumina Clinical Associates Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Lancaster : Urological Associates Of Lancaster

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Lancaster : Urological Associates of Lancaster

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lancaster : Urological Associates of Lancaster

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Lancaster : Urological Associates of Lancaster Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Lancaster : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Lancaster : Regional Gastroenterology Associates of Lancaster, LTD

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Lemoyne : 1200.75.10018 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Perkasie : Main Line Gastroenterology Updated

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Perkasie : Main Line Gastroenterology

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Philadelphia :

A Dose-escalation Study in Subjects With Advanced Malignancies

Philadelphia : Pfizer Investigational Site

A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors

Philadelphia :

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Philadelphia : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

Philadelphia : Pfizer Investigational Site

A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors

Philadelphia : Fox Chase Cancer Center

A Safety Study of Oral ZSTK474 in Patients With Cancer

Philadelphia : Site Reference ID/Investigator# 23286 Updated

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

Philadelphia : Thomas Jefferson University Hospital

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Philadelphia : University of Pennsylvania Abramson Cancer Center

A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer

Philadelphia :

A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Philadelphia : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Philadelphia :

A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Philadelphia : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Philadelphia : Hospital of the University of Pennsylvania Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Philadelphia : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Philadelphia : PGC Endoscopy Center Inc.

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Philadelphia : Fox Chase Cancer Center

Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Philadelphia :

Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors

Philadelphia : Pennsylvania Oncology Hematology Associates

Safety Study of PLX108-01 in Patients With Solid Tumors

Philadelphia : Hospital Of The University Of Pennsylvania

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors

Philadelphia :

Sorafenib Long Term Extension Program (STEP)

Philadelphia : Research Site

Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours

Philadelphia : Fox Chase Cancer Center

Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma

Philadelphia : Investigational Site Number 1134

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Philadelphia : Research Site

Study to Assess Safety, Tolerability and PK of AZD1480 Alone or in Comb With Docetaxel in Patients With Solid Tumours

Philadelphia : Fox Chase Cancer Center

Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors

Philadelphia : Fox Chase Cancer Center Updated

Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors

Philadelphia : Pennsylvania Oncology

Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors

Pittsburgh : University of Pittsburgh

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Pittsburgh :

BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer

Pittsburgh : Pittsburgh Gynecologic Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

Pittsburgh : University of Pittsburgh Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Pittsburgh : Triangle Urological Group Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Pittsburgh : UPMC Shadyside Radiation Oncology

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

Pittsburgh : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Pittsburgh : Hillman Cancer Center

Pilot Study for Locally Advanced Head and Neck Cancer

Pittsburgh : Allegheny General Hospital

Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery

Pittsburgh, : University of Pittsburgh

An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

Rockledge : Fox Chase Cancer Center

An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors

Sayre : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

State College : Mount Nittany Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

State College : Mount Nittany Physician Group Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

West Reading : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

West Reading : Reading Hospital and Medical Center

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Willow Grove : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Cranston : Hematology Oncology Associatesof Rhode Island

NP2 Enkephalin For Treatment of Intractable Cancer Pain

East Providence : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

East Providence : Pharma Resource Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Providence : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Providence : Investigational Site Number 1142

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

View More »

Providence : Bayside Endoscopy Center

Third Eye Retroscope Randomized Clinical Evaluation

Charleston : Pfizer Investigational Site

A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors

Charleston : Charleston Hematology Oncology Associates, PA

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Charleston : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Charleston : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Charleston : Medical University of South Carolina (MUSC)

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

View More »

Charleston : Medical University of South Carolina

Tracking Renal Tumors After Cryoablation Evaluation

Columbia : South Carolina Oncology Associates, PA

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Columbia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Columbia : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Greenville : Call for Information (Investigational Site 0011)

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)

Greenville : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Greenville : Cancer Center of the Carolinas

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Greenville : Novartis Investigative Site

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

Mrytle Beach : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Mt. Pleasant : Coastal Carolina Research Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Myrtle Beach : Carolina Urologic Research Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Myrtle Beach : Carolina Urologic Research Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Myrtle Beach : Carolina Urologic Research Center

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Myrtle Beach : Carolina Urologic Research Center

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Myrtle Beach : Carolina Urologic Research Center Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Myrtle Beach : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Myrtle Beach : Grand Strand Urology

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

West Columbia : Lexington Oncology Associates, LLC

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Rapid City : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Sioux Falls : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Sioux Falls : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Sioux Falls : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Sioux Falls : Sandford USD Health System

ChemoFx® PRO - A Post-Market Data Collection Study

View More »

Watertown : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Bartlett : University of Tennessee Cancer Institute

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Chattanooga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Chattanooga : Chattanooga Gynecologic Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

Chattanooga : Chattanooga's Program in Women's Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

Germantown : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

View More »

Germantown : Gastro One

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Germantown : Gastro One

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Germantown : University of Tennessee Cancer Institute

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Kingsport : Gastroenterology Associates of Clinical Research

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Knoxville : Thomas W. McDonald MD

ChemoFx® PRO - A Post-Market Data Collection Study

Knoxville : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Memphis : The West Clinic

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Memphis : The West Clinic

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Memphis : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Memphis : The West Clinic

A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors

Memphis : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Memphis : St. Jude Children's Research Hospital

A Trial of RAD001 and Avastin in Children With Recurrent Solid Tumors

Memphis : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Memphis : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Memphis : University of Tennessee Cancer Institute

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Memphis : Call for Information (Investigational Site 0005)

Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)

Memphis : The West Clinic

Tesetaxel as First-line Therapy for Metastatic Breast Cancer

Nashville : Sarah Cannon Cancer Research Institute

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Dose-Escalation Study in Participants With Advanced Cancer

Nashville :

A Dose-escalation Study in Subjects With Advanced Malignancies

Nashville : Pfizer Investigational Site

A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors

Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Phase 1 Study in Advanced Cancer

Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Phase 1 Study in Patients With Advanced Cancer

Nashville : Sarah Cannon Research Institute

A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies

Nashville : Urology Associates, PC

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Nashville : Sarah Cannon Research Institute

A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors

Nashville : Vanderbilt University Medical Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Nashville : Urology Associates, P.C.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Nashville : Pfizer Investigational Site

A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors

Nashville :

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma

Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Nashville : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Nashville : Sarah Cannon Research Institute

A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers

Nashville : Sarah Cannon Research Institute Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Nashville :

A Study of GDC-0575 Alone And in Combination With Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma

Nashville : Sarah Cannon Research Institute (SCRI)

A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors

Nashville : Investigational Site Number 840002

A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers

Nashville : Novartis Investigative Site

A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors

Nashville : Urology Associates, PC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Nashville : Sarah Cannon Research Institute

A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor

Nashville : Tennessee Oncology

A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors

Nashville : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

Nashville : Novartis Investigative Site

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma

Nashville : Tennessee Oncology, PLLC

A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors

Nashville : Novartis Investigative Site

Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors

Nashville : Novartis Investigative Site Updated

Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors

Nashville : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Nashville : Investigational Site Number 840001

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

Nashville :

Dose Escalation Study of INK128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

Nashville :

Dose Escalation Study of INK128 in Subjects With Advanced Cancer

Nashville : The Sarah Cannon Research Institute

Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors

Nashville : Vanderbilt University Medical Center Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Nashville : Vanderbilt University

IDO Inhibitor Study for Relapsed or Refractory Solid Tumors

Nashville : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Notch Inhibitor in Advanced Cancer

Nashville : Sarah Cannon Research - Drug Development Unit

Oral Azacitidine as a Single Agent and in Combination With Carboplatin or Abraxane® in Subjects With Relapsed or Refractory Solid Tumors

Nashville : Investigational Site Number 840003

Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors

Nashville : The Sarah Cannon Research Institute

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

Nashville : Tennessee Oncology, PLLC

Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors

Nashville : Sarah Cannon Research Institute

Safety and PK Study of RRx-001 in Cancer Subjects

Nashville : Vanderbilt-Ingram Medical Center

Safety Study of PLX108-01 in Patients With Solid Tumors

Nashville : Sarah Cannon Research Institute

Safety Study of X-82 in Patients With Advanced Solid Tumors

Nashville : Research Site

Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours

Nashville : Sarah Cannon Research Institute Tennessee Oncology Drug Development Unit

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Nashville : Sarah Cannon Research Institute

Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer

Nashville : Jeffrey R. Infante

Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors

Nashville : Tennessee Oncology

Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors

Nashville : Sarah Cannon Research Institute

Study of PWT33597 Mesylate in Subjects With Advanced Malignancies

Nashville : Sarah Cannon Research Institute

Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors

Nashville : Vanderbilt University

Tracking Renal Tumors After Cryoablation Evaluation

Nashville : Monroe Carell Jr. Children's Hospital at Vanderbilt

Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

Nashville :

Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors

Nashville : Sarah Cannon Research Institute

Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

Nashville, : The Vanderbilt-Ingram Cancer Center

Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Abilene : Hendrick Medical Center / Hendrick Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Abilene : Texas Cancer Center Abilene, Texas Oncology P.A.

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Amarillo : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Arlington : Arlington Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Arlington : Texas Oncology - Arlington North

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View More »

Arlington : Texas Oncology - Arlington South

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Arlington : Urology Associates of North Texas Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Austin : Texas Oncology - Austin Midtown

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Austin : Texas Oncology - Austin North

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Austin : Texas Oncolocy - South Austin

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Austin : Professional Quality Research, Inc. Updated

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Austin : Professional Quality Research, Inc.

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Autstin : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Beaumont : Texas Oncology - Beaumont, Mamie McFaddin Ward Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Bedford : Texas Oncology, P.A.

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Cedar Park : Texas Oncology - Cedar Park

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Corpus Christi : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Corpus Christi : 1200.75.10037 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Dallas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Dose-Escalation Study in Participants With Advanced Cancer

Dallas : Texas Oncology, P.A.

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Dallas : Urology Clinics of North Texas

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Dallas : Texas Oncology - Baylor Charles A. Sammons Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Dallas : Texas Oncology - Dallas Presbyterian Hospital

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Dallas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Dallas : Mary Crowley Cancer Research Centers - Medical City Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Dallas : North Texas Gynecologic Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

Dallas : UT Southwestern Medical Center - Simmons Cancer Center

Clinical Trial of ARQ 761 in Advanced Solid Tumors

Dallas : Urology Clinics of North Texas, PA Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Dallas : Mary Crowley Cancer Center

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Dallas : Mary Crowley Cancer Research Center

Phase 1 Study of ONT-10 in Patients With Solid Tumors

Dallas : Mary Crowley Cancer Research Centers

Phase 1 Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma

Dallas : Mary Crowley Cancer Research Centers

Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer

Dallas : Mary Crowley Cancer Research Centers

Phase I, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers

Dallas : Mary Crowley Cancer Research Centers

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Dallas : Mary Crowley Cancer Research Centers (MCCRC)

Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies

Dallas : Mary Crowley Medical Research Center

Safety Study of Infusion of SGT-53 to Treat Solid Tumors

Dallas : Texas Oncology, PA (North)

Safety Study of PLX108-01 in Patients With Solid Tumors

Denton : Texas Oncology - Denton South

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

El Paso : Texas Oncology - El Paso Cancer Treatment Center Gateway

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

El Paso : Texas Oncology - El Paso Cancer Treatment Center Grandview

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fort Worth : Texas Oncology - Fort Worth 12th Avenue

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fort Worth : Texas Oncology - Southwest Fort Worth

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fort Worth : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Fort Worth : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Ft. Sam Houston : Brooke Army Medical Center

ChemoFx® PRO - A Post-Market Data Collection Study

Galveston : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Grapevine : Texas Oncology

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Houston : UT MD Anderson Cancer Center

4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies

Houston : UT MD Anderson Cancer Center Updated

5-Azacytidine and Oxaliplatin With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy

Houston : Research Site Updated

A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

Houston : MD Anderson Cancer Center

A Dose Escalation Study of an Antibody in Patients With Advanced Cancers

Houston : M.D. Anderson Cancer Institute

A Dose Escalation Study of an Antibody in Patients With Advanced Cancers

Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Phase 1 Study in Patients With Advanced Cancer

Houston : Research Site

A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors

Houston : Research Site

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors

Houston : University of Texas, M.D. Anderson Cancer Center

A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors

Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Head and Neck Cancer

Houston : Research Site

A Study of AMG 337 in Subjects With Advanced Solid Tumors

Houston : The University Of Texas Md Anderson Cancer Center

A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Houston : Call for Information (Investigational Site 0012)

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)

Houston : Pfizer Investigational Site

A Study Of PF-04449913 In Select Hematologic Malignancies

Houston : The University of Texas M. D. Anderson Cancer Center

A Study of QBI-139 in Subjects With Advanced Solid Tumors

Houston :

A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Houston : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Houston : Novartis Investigative Site

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

Houston : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Houston : Site Reference ID/Investigator# 26524

ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors

Houston : 1200.89.10004 Boehringer Ingelheim Investigational Site

Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer

Houston : UT MD Anderson Cancer Center

Bendamustine and Bevacizumab for Advanced Cancers

Houston : UT MD Anderson Cancer Center

Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors

Houston : The University of Texas MD Anderson Cancer Center

Combination Trial MSC1936369B With Temsirolimus

Houston : UT MD Anderson Cancer Center

Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy

Houston : GSK Investigational Site

Dose-Escalation Study of GSK2126458

Houston : U T M D Anderson Cancer Center

Dose-escalation Study of Oral CX-4945

Houston : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Houston : M.D. Anderson Cancer Center

First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors

Houston : M.D. Anderson Cancer Center

First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor EMD 1214063 in Subjects With Advanced Solid Tumors

Houston : UT MD Anderson Cancer Center

Fludarabine, Bendamustine and Rituximab Conditioning for Patients With Lymphoid Malignancies

Houston : UT MD Anderson Cancer Center

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Houston : MD Anderson Cancer Center

MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

Houston : Gastroenterology Associates, PA

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Houston : Advanced Clinical Research of Houston

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Houston : Research Site

Panitumumab Pediatric Study

Houston : UT MD Anderson Cancer Center

Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients

Houston : UT MD Anderson Cancer Center

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies

Houston :

Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer

Houston : MD Anderson Cancer Center

Phase I, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers

Houston :

Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With MEK (Mitogen-activated Protein Kinase) Inhibitor BAY86-9766 in Patients With Advanced Cancer

Houston : UT MD Anderson Cancer Center

Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)

Houston : University of Texas M.D. Anderson Cancer Center

Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases

Houston : University of Texas MD Anderson Cancer Center

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

Houston : Call for Information (Investigational Site 0002)

Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)

Houston : Novartis Investigative Site

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

Houston : MD Anderson Cancer Center

Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib and GSK1120212 in Advanced Solid Tumors Enriched With Patients With Advanced Differentiated Thyroid Cancer

Houston : Research Site

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders

Houston : Oncology Consultants

Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer

Houston : MD Anderson Cancer Center

Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies

Houston : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Houston : MD Anderson Cancer Center

Study of KB004 in Subjects With Hematologic Malignancies

Houston : University of Texas - MD Anderson Cancer Center

Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma

Houston : UT MD Anderson Cancer Center

Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors

Houston : UT MD Anderson Cancer Center

Tolvaptan in Hyponatremic Cancer Patients

Houston : University of Texas - MD Anderson Cancer Center

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Killeen : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Kyle : Texas Oncology - Kyle

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lewisville : Texas Oncology - Lewisville

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lubbock : 1200.75.10014 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Lubbock : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

McAllen : Urology Associates of South Texas

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Mcallen : Urology Associates of South Texas Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Midland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Paris : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Round Rock : Texas Oncology - Round Rock

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Round Rock : Texas Oncology - Seton-Williamson

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Round Rock : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

San Antonio : Call for Information (Investigational Site 0001)

A Combination Therapy Study of MK2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010 AM5)

San Antonio : Investigational Site Number 840006

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

San Antonio : South Texas Accelerated Research Therapeutics

A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors

San Antonio : South Texas Accelerated Research Therapeutics

A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors

San Antonio : South Texas Accelerated Research Therapeutics

A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas

San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician

A Phase 1 Study of LY2835219 In Subjects With Advanced Cancer

San Antonio : University of Texas Health Science Center at San Antonio

A Phase 1 Study of MLN8237 in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen

San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

San Antonio : South Texas Accelerated Research Therapeutics (START)

A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers

San Antonio : South Texas Accelerated Research Therapeutics, LLC

A Study of DS-2248, in Subjects With Advanced Solid Tumors

San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2228820 in Patients With Advanced Cancer

San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY3007113 in Patients With Advanced Cancer

San Antonio : Urology San Antonio Research, PA

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

San Antonio : South Texas Accelerated Research Therapeutics, LLC

A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer

San Antonio :

A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors

San Antonio : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

San Antonio : Methodist Hospital - Texas Transplant Institute

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

San Antonio : InVisions Consultants, LLC- c/o Institute for Women's Health

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

San Antonio : InVisions Consultants, LLC

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

San Antonio :

BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer

San Antonio : Novartis Investigative Site Updated

Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors

San Antonio : South Texas Gynecologic Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

San Antonio : University of Texas, Health Science Center,Cancer Therapy and Research Center

Dose-Escalation Phase 1 Study of G-202 in Patients With Advanced Solid Tumors

San Antonio : South Texas Accelerated Research Therapeutics, LLC

Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors

San Antonio : Investigational Site Number 840001

First in Man Study of SAR566658 Administered Every 3 Weeks in Patients With DS6-positive and Refractory Solid Tumors

San Antonio : Cancer Therapy & Research Center at UTHSCSA

Hydroxychloroquine + Vorinostat in Advanced Solid Tumors

San Antonio : Medical Therapy and Research

NP2 Enkephalin For Treatment of Intractable Cancer Pain

San Antonio : START

Oral Azacitidine as a Single Agent and in Combination With Carboplatin or Abraxane® in Subjects With Relapsed or Refractory Solid Tumors

San Antonio :

Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors

San Antonio : South Texas Accelerated Research Therapeutics (START)

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma

San Antonio : Investigational Site Number 840006 Updated

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

San Antonio : South Texas Accelerated Research Therapeutics (START)

Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies

San Antonio : South Texas Accelerated Research Therapeutics

Safety Study of AB0024 in Patients With Advanced Solid Tumors

San Antonio : START (South Texas Accelerated Research Therapeutics)

Safety Study of CALAA-01 to Treat Solid Tumor Cancers

San Antonio : South Texas Accelerated Research Therapeutics, LLC (START)

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

San Antonio : Urology San Antonio Research

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

San Antonio :

Sorafenib Long Term Extension Program (STEP)

San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study in Head and Neck Cancer

San Antonio : South Texas Accelerated Research Therapeutics, LLC

Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)

San Antonio : Cancer Therapy and Research Center

Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer

San Antonio : South Texas Accelerated Research Therapeutics, LLC (START)

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

San Antonio : University of Texas Health Science Center San Antonio

Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors

San Antonio : The START Center

Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma

San Antonio : Cancer Therapy & Research Center at the UT Health Science Center

Study of MLN4924 in Adult Patients With Nonhematologic Malignancies

San Antonio : Institute for Drug Development

Study of MLN4924 in Adult Patients With Nonhematologic Malignancies

San Antonio : South Texas Accelerated Research Therapeutics (START)

Study of NMS-1116354 in Solid Tumors

San Antonio : South Texas Accelerated Research Therapeutics (START)

Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic Malignancies

San Antonio : START- South Texas Accelerated Research Therapeutics, LLC

Study of PM060184 in Patients With Advanced Solid Tumors

San Marcos : Texas Oncology - San Marcos

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Sherman : Texas Oncology - Sherman

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Sugar Land : Texas Oncology - Sugar Land

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Temple : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

The Woodlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Dose-Escalation Study in Participants With Advanced Cancer

The Woodlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Tyler : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Dose-Escalation Study in Participants With Advanced Cancer

Tyler : Tyler Cancer Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Tyler : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Tyler : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Tyler : Digestive Health Specialists

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Tyler : Digestive Health Specialists of Tyler

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Tyler : Tyler Cancer Center, Texas Oncology

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Webster : Texas Oncology - Deke Slayton Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Logan : Advanced Research Institute

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Murray : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Ogden : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Ogden : Advanced Research Institute Updated

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Ogden : Advanced Research Institute

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

View More »

Salt Lake City : Novartis Investigative Site

A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors

Salt Lake City : Huntsman Cancer Center, University of Utah

A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies

Salt Lake City :

A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Salt Lake City : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Salt Lake City : Wasatch Clinical Research

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Salt Lake City : Novartis Investigative Site

Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors

Salt Lake City : Novartis Investigative Site Updated

Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors

Salt Lake City : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Salt Lake City : Investigational Site Number 840002

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

Salt Lake City : GSK Investigational Site

Dose-Escalation Study of GSK2126458

Salt Lake City : Novartis Investigative Site

MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations

Salt Lake City : Huntsman Cancer Institute

MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

Salt Lake City : University of Utah

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Salt Lake City : Salt Lake Research, PLLC

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Salt Lake City : Huntsman Cancer Center

Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function

Salt Lake City : University of Utah

Phase 1 Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma

Salt Lake City : GSK Investigational Site

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Salt Lake City : Huntsman Cancer Institute

Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic Malignancies

Salt Lake City : Novartis Investigative Site

Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function

Sandy : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Sandy : Advanced Research Institute Updated

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Sandy : Advanced Research Institute

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Burlington : 1200.75.10011 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Annandale : North Virigina Pelvic Surgery Associates

ChemoFx® PRO - A Post-Market Data Collection Study

Charlottesville : University of Virginia Health System Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Charlottesville : Charlottesville Medical Research

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Charlottesville : University of Virginia

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer

Chesapeake : Chesapeake Regional Medical Center

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

View More »

Chesapeake : Gastroenterology Associates of Tidewater

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Hampton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

McLean : National Center for Plastic Surgery

Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study

Norfolk : Urology of Virginia / SMG

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Norfolk : Urology of Virginia, Sentara Medical Group

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Norfolk : Digestive and Liver Disease Specialists

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Norfolk : Clinical Research Associates of Tidewater

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Norfolk : Gastroenterology Associates of Tidewater

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Norfolk : Digestive and Liver Disease Specialists

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Norfolk :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Richmond : McGuire Veterans Affairs Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Richmond : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Richmond : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Roanoke : Carilion Clinic Gynecologic Oncology

ChemoFx® PRO - A Post-Market Data Collection Study

Roanoke : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Virginia Beach : Urology of Virginia

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Virginia Beach : Gastroenterology Associates of Tidewater

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Bellevue : Northwest Gastroenterology Associates

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Burien : Seattle Urology Research Center

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Burien : Seattle Urology Research Center Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Renton : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Seattle : Seattle Cancer Care Alliance

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

View More »

Seattle : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Seattle : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer

Seattle : Site Reference ID/Investigator# 23285 Updated

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

Seattle : Pfizer Investigational Site

A Study Of PF-04449913 In Select Hematologic Malignancies

Seattle :

A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors

Seattle : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Seattle : Swedish Cancer Institute

Breath Test for Early Detection of Lung Cancer

Seattle : Virginia Mason Medical Center

Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Seattle : GSK Investigational Site

Dose-Escalation Study of GSK2126458

Seattle : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Seattle : Fred Hutchinson Cancer Research Center

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

Seattle : Seattle Cancer Care Alliance/Fred Hutchinson Cancer Res Ctr/Univ. of Washington Med Ctr

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Seattle : Virginia Mason Medical Center

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Seattle : Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

Spokane : Medical Oncology Associates, PS

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Spokane : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Spokane : Medical Oncology Associates

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Spokane : Evergreen Hematology & Oncology

Safety Study of PLX108-01 in Patients With Solid Tumors

Spokane Valley : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Tacoma :

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Tacoma : Site Reference ID/Investigator# 43422

A Study of ABT-806 in Subjects With Advanced Solid Tumor Types

Tacoma : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Tacoma : Comprehensive Clinical Development NW, Inc.

A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body

Tacoma : Site Reference ID/Investigator# 53008

An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors

Vancouver : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Dose-Escalation Study in Participants With Advanced Cancer

Vancouver : Northwest Cancer Specialists, P.C.

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Vancouver : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Wenatchee : Wenatchee Valley Medical Center

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Wenatchee : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Wenatchee : GSK Investigational Site

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

Wenatchee : 1200.75.10024 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Beckley : Raleigh Regional Cancer Center

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Elkins : Davis Memorial Cancer Care Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Morgantown : Research Site Updated

A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

Morgantown : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Morgantown : Mohammed Ashraf MD

ChemoFx® PRO - A Post-Market Data Collection Study

View More »

Wheeling : The Schiffler Cancer Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Green Bay : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study for Patients With Pancreatic Cancer

Green Bay : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

La Crosse : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

La Crosse : Gundersen Lutheran

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Madison :

A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

View More »

Madison : University of Wisconsin Comprehensive Cancer Center

A Study of QBI-139 in Subjects With Advanced Solid Tumors

Madison : University of Wisconsin Madison, Carbone Cancer Center

A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Advanced Prostate Cancer

Madison : University Of Wisconsin

Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors

Madison : University of Wisconsin Paul P Carbone Comprehensive Cancer Center

Dose-Escalation Phase 1 Study of G-202 in Patients With Advanced Solid Tumors

Madison : Kenneth DeSantes., MD

Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors

Madison : GI Research

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Madison : University of Wisconsin Paul P. Carbone Comprehensive Cancer Center

Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies

Madison : University of Wisconsin Carbone Cancer Center

Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib

Madison : Novartis Investigative Site

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

Marshfield : Marshfield Clinic

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Milwaukee : Medical College of Wisconsin, Inc. Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Milwaukee : Updated

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Milwaukee : Wisconsin Center for Advanced Research

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Milwaukee : Children's Hospital of Wisconsin

Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

Waukesha : Waukesha Memorial Hospital (ProHealth Care)

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Wauwatosa : Call for Information

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

West Allis : Aurora West Allis Medical Center

ChemoFx® PRO - A Post-Market Data Collection Study

Weston : Marshfield Clinic Weston Center

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Buenos Aires : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Buenos Aires : 1200.75.54005 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Capital Federal : 1200.75.54001 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Ciudad Autonoma de Buenos Aires : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Cordoba : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

View More »

La Plata : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Mendoza : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Quilmes : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Quilmes : 1200.75.54003 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Rosario : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Rosario : 1200.75.54004 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Rosario : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Santa Fe : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Vicente Lopez : Htal Vicente Lopez

Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine Patients

Adelaide : 1200.131.06152 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Adelaide : The Queen Elizabeth Hospital

Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer

Adelaide : Royal Adelaide Hospital

Study of KB004 in Subjects With Hematologic Malignancies

Adelaide SA : RAH Cancer Centre, Royal Adelaide Hospital

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Bentleigh East : Research Site

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

View More »

Bentleigh East : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Box Hill : Investigational Site Number 036004

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Box Hill : 1200.75.61005 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Box Hill : Investigational Site Number 036001 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Campbelltown : Investigational Site Number 036020

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Camperdown : Investigational Site Number 036001

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Camperdown : Investigational Site Number 036002

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Clayton : Investigational Site Number 036001 Updated

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Douglas : Investigational Site Number 036011

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

East Bentleigh : 1200.89.61002 Boehringer Ingelheim Investigational Site

Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer

East Melbourne : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2874455 in Patients With Advanced Cancer

East Melbourne : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

East Melbourne : Novartis Investigative Site

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Fitzroy : 1200.75.61001 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Footscray : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

Heidelberg : Site Reference ID/Investigator# 52203

An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types

Heidelberg : Site Reference ID/Investigator# 60619

An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors

Heidelberg : 1200.123.6105 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Heidelberg (Melbourne) : Ludwig Institute Tumor Targeting Program, Austin Health

An Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer

Hobart : 1200.131.06153 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Kingswood : Investigational Site Number 036002 Updated

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Kogarah : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Kogarah : Investigational Site Number 036004 Updated

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Kurralta Park : Research Site

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Kurralta Park : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Melbourne : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Melbourne : Peter MacCallum Cancen Center

Phase 1 Clinical Trial in Patients With Advanced Malignancies

Melbourne : The Alfred Hospital

Phase 1 Clinical Trial in Patients With Advanced Malignancies

Nambour : Investigational Site Number 036019

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Nedlands : 1200.123.6106 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Nedlands : Linear Clinical Research Ltd

Study of the Safety and Tolerability of PG545 in Patients With Advanced Solid Tumours

North Adelaide : Investigational Site Number 036023

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Parkville : Research Site

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Parkville : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

Parkville : Novartis Investigative Site

A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors

Parkville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2874455 in Patients With Advanced Cancer

Parkville : Investigational Site Number 036008

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Parkville : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Parkville : Novartis Investigative Site

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

Perth : Investigational Site Number 036005

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Perth : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Perth : Royal Perth Hospital

Phase 1 Clinical Trial in Patients With Advanced Malignancies

Perth : GSK Investigational Site

The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Port Macquarie : Investigational Site Number 036003

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Port Macquarie : 1200.75.61002 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Prahran : The Alfred Hospital

Study of KB004 in Subjects With Hematologic Malignancies

Randwick : Investigational Site Number 036025

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Randwick : Research Site Updated

Phase I Comparative Bioavailability Study

Randwick : Investigational Site Number 036003 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Randwick :

Sorafenib Long Term Extension Program (STEP)

Randwick : Investigational Site Number 036003 Updated

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Ringwood East : 1200.75.61004 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

South Brisbane : 1200.89.61001 Boehringer Ingelheim Investigational Site

Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer

South Brisbane : Investigational Site Number 036022

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

South Brisbane : Investigational Site Number 036009

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

South Brisbane : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

South Brisbane : 1200.123.6103 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

South Brisbane : Mater Adult Hospital

Phase 1 Clinical Trial in Patients With Advanced Malignancies

South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Southport : Investigational Site Number 036017

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

St Leonards : Investigational Site Number 036012

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Sydney : Investigational Site Number 036013

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Sydney : Investigational Site Number 036010

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Sydney : The Mater Hospital

Use of Hair to Diagnose Breast Cancer

Tweed Heads : Investigational Site Number 036016

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Victoria : Updated

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Wahroonga : 1200.75.61003 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Wendouree : Investigational Site Number 036024

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Westmead : Investigational Site Number 036007

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Westmead : Westmead Hospital

Trial of MSC1936369B in Subjects With Solid Tumours

Wodonga : Investigational Site Number 036015

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Wodonga : Border Medical Oncology

Phase 1 Clinical Trial in Patients With Advanced Malignancies

Wodonga : Investigational Site Number 036002 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Woodville South : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Woodville South : The Queen Elizabeth Hospital

Phase 1 Clinical Trial in Patients With Advanced Malignancies

Wooloongabba : 1200.131.06151 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Graz : 1200.75.43003 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Graz : Graz Medical University

Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.

Innsbruck : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Leoben : 1200.43.04303 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Linz : 1200.75.43002 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

View More »

Salzburg : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Salzburg : 1200.43.04305 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Salzburg : 1200.131.04355 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Steyr : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Vienna : Merck Sharp & Dohme Gmbh

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Vienna : 1200.75.43005 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Wien : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Wien : 1200.75.43001 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Wien : 1200.75.43004 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Wien : 1200.43.04301 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Wien : 1200.131.04351 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Antwerp : AZ Stuivenberg

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Antwerp : ZNA Middelheim Oncologie

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Antwerpen : 1200.75.32004 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Antwerpen : Investigational Site Number 056003 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Brasschaat : 1200.75.32008 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

View More »

Brussel : University Ziekenhuis

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Brussels :

A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Brussels : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Brussels : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Brussels : Jules Bordet Institute

Trial of MSC1936369B in Subjects With Solid Tumours

Bruxelles : Merck Sharp & Dohme B.V.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Bruxelles : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Bruxelles :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Bruxelles : 1200.75.32001 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Bruxelles : 1200.43.03202 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Bruxelles : 1287.1.3201 Boehringer Ingelheim Investigational Site

Monotherapy Dose Finding With BI 847325 in Solid Tumours

Bruxelles : Investigational Site Number 056002 Updated

Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment

Bruxelles : Investigational Site Number 056002 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Bruxelles : Hôpital Erasme

Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)

Bruxelles : Hôpital Saint Pierre

Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)

Bruxelles : CHU Brugmann

Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)

Bruxelles : Institut Jules Bordet

Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma

Bruxelles - Brussel :

Combination With Gemcitabine in Advanced Pancreatic Cancer

Bruxelles - Brussel :

Sorafenib Long Term Extension Program (STEP)

Charleroi : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Charleroi : 1200.131.03256 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Charleroi :

Sorafenib Long Term Extension Program (STEP)

Edegem :

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Edegem :

Combination With Gemcitabine in Advanced Pancreatic Cancer

Edegem : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Edegem : 1200.75.32005 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Edegem : 1200.43.03203 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Edegem : 1200.131.03251 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Edegem : Investigational Site Number 3219

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Gent : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Gent : 1200.43.03204 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Gent : Investigational Site Number 056001 Updated

Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment

Ghent : Ghent University Hospital

Trial of MSC1936369B in Subjects With Solid Tumours

Hasselt : 1200.131.03255 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Ixelles : HIS Ixelles

Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)

Jette : AZ VUB

First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene

Jette : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Kortrijk : 1200.131.03253 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Kortrijk : Investigational Site Number 3212

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Leuven : Research Site Updated

A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

Leuven : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

Leuven : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Leuven : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Leuven : 1200.43.03201 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Leuven : 1287.1.3202 Boehringer Ingelheim Investigational Site

Monotherapy Dose Finding With BI 847325 in Solid Tumours

Leuven : Research Site Updated

Phase I Comparative Bioavailability Study

Leuven : Investigational Site Number 056001 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Leuven : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Leuven : University Hospitals Leuven

Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

Leuven : Investigational Site Number 3211

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Libramont : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Liege : CHR Citadelle

Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)

Liege : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Liège : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

Liège : 1200.75.32003 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Liège : 1200.131.03254 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Liège : 1200.131.03252 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Namur : GSK Investigational Site Updated

A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Namur : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Namur : Investigational Site Number 3213

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Oostende : 1200.75.32007 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Turnhout : AZ Turnhout Dienst Urologie

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Wilrijk :

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Wilrijk : Research Site

A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer

Wilrijk :

A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Wilrijk : Novartis Investigative Site Updated

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

Wilrijk : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Wilrijk : Investigational Site Number 3218

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer

Yvoir : Research Site Updated

A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

Yvoir : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Banja Luka : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Mostar : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Sarajevo : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Sarajevo : Klinicki Centar Univerziteta Sarajevo - Klinika za gastroenterohepatologiju

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Tuzla : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Belo Horizonte : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Cachoeiro de Itapemirim : 1200.75.55003 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Campinas : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Curitba : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Curitiba : 1200.75.55010 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

View More »

Goiania : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Goiânia/Go : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Ijui : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Ijuí : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

ItajaÃ- : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Porto Alegre : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Porto Alegre : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Porto Alegre : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Porto Alegre : 1200.75.55005 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Porto Alegre : 1200.75.55002 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Porto Alegre : 1200.75.55008 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Porto Alegre : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Ribeirão Preto : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Ribeirão Preto/Sp : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Rio de Janeiro : 1200.75.55004 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Rio de Janeiro : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

São Paulo : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Salvador : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Santo Andre : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Sao Jose Do Rio Preto : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Sao Paulo :

Sorafenib Long Term Extension Program (STEP)

Sao Paulo : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

São Paulo : 1200.75.55007 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Vila Belmiro : 1200.75.55001 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Plovdiv : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Shoumen : Site 1

Tapentadol in Chronic Malignant Tumour Related

Sofia : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Sofia : GSK Investigational Site Updated

A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Sofia : Merck Sharp & Dohme IDEA Inc.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

View More »

Sofia : Investigational Site Number 100001

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Stara Zagora : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Varna : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Varna : GSK Investigational Site Updated

A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Abbotsford : Exdeo Clinical Research Inc.

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Abbotsford : Investigational Site Number 124015

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Brampton : Investigational Site Number 124018

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Brantford : Brandord Urology Research

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Burnaby : Investigational Site Number 124014

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

View More »

Calgary : Tom Baker Cancer Center

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Calgary : University of Calgary

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Calgary : University of Calgary

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Calgary :

Sorafenib Long Term Extension Program (STEP)

Edmonton : Cross Cancer Center

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Edmonton : Updated

A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer

Edmonton : Local Institution

Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers

Edmonton : 1200.92.1001 Boehringer Ingelheim Investigational Site

BIBW 2992 (Afatinib) in Combination With Pemetrexed in Advanced Solid Tumours

Edmonton : Cross Cancer Institute

First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.

Edmonton : GSK Investigational Site

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

Edmonton : 1200.67.11001 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Edmonton : 1200.123.1005 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Edmonton : Novartis Investigative Site

MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations

Edmonton : University of Alberta Cross Cancer Institute

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Edmonton : GSK Investigational Site

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Edmonton :

Sorafenib Long Term Extension Program (STEP)

Granby : Theradev Clinical Research

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Greenfield Park : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Greenfield Park : 1200.67.11003 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Greenfield Park : Investigational Site Number 124011

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Halifax : GSK Investigational Site

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

Halifax : GSK Investigational Site

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Halifax : Queen Elizabeth II Health Sciences Centre

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Hamilton : Juravinski Cancer Centre

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Hamilton : 1200.92.1002 Boehringer Ingelheim Investigational Site

BIBW 2992 (Afatinib) in Combination With Pemetrexed in Advanced Solid Tumours

Hamilton : Juravinski Cancer Centre

Low Dose Radiation Therapy as Chemosensitizer in GI/ Ovarian Tumors

Hamilton : Investigational Site Number 124010

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Hamilton : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Hamilton : Juravinski Hospital & Cancer Centre

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Kelowna : Southern Interior Medical Research, Inc. Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Kingston : Centre for Applied Urological Research, Queen's University

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Kirkland : Merck Frosst Canada Ltd.

A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)

Kirkland : Merck Frosst Canada Ltd.

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646-027 AM2)

Kirkland : Merck Frosst Canada Ltd.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Kitchener : 1200.75.11004 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Laval : Investigational Site Number 124009

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

London : London Health Sciences Centre Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Moncton : Investigational Site Number 124007

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Moncton : 1200.75.11002 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Montreal : Research Site Updated

A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

Montreal :

A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia

Montreal : CHUM-Hospital Notre Dame

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Montreal : McGill University

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Montreal : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Head and Neck Cancer

Montreal : MUHC- Montreal General Hospital

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Montreal : The Urology Specialists

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Montreal : Investigational Site Number 124001

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Montreal : 1200.75.11001 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Montreal : 1200.67.11002 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Montreal : 1200.131.00153 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Montreal : 1200.131.00154 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Montreal : 1200.123.1001 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Montreal : 1200.123.1007 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Montreal : Novartis Investigative Site

MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations

Montreal :

Sorafenib Long Term Extension Program (STEP)

Montreal : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study in Head and Neck Cancer

Montreal : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Montreal : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Montreal : Investigational Site Number 124002 Updated

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Montreal : Hopital Maisonneuve-Rosemont

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Montréal : Investigational Site Number 124001 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Newmarket : Mor Urology Inc. Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

North Bay : Office of Dr. Bernard Goldfarb Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Oakville : The Fe/Male Health Centres Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Oshawa : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Oshawa : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Oshawa : 1200.123.1006 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Oshawa : Investigational Site Number 124013

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Ottawa :

A Study of RO5458640 in Patients With Advanced Solid Tumors

Ottawa : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Ottawa : Investigational Site Number 124012

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Ottawa : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Ottawa : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Pointe-Claire : Ultra-Med, Inc. Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Province of British Columbia : Can-Med Clinical Research Inc.

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Québec : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Quebec : Investigational Site Number 124010

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Quebec : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Québec : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Quebec City : Centre Hospitalier Universitaire de Quebec- L'Hotel-Dieu de Quebec Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Saint John : Investigational Site Number 124002 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Saskatoon : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Scarborough : Urology and Male Infertility Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Sherbrooke : GSK Investigational Site

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

Sherbrooke : Investigational Site Number 124004

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Sherbrooke : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Sudbury : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Sudbury : Investigational Site Number 124008

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Surrey : 1200.123.1004 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Surrey : Investigational Site Number 124007

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Toronto : Novartis Investigative Site

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Toronto :

A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia

Toronto : Princess Margaret Hospital

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Toronto : Princess Margaret Hospital

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Toronto : 1300.2.1001 Boehringer Ingelheim Investigational Site

A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer

Toronto : Local Institution

A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Toronto :

A Study of RO5458640 in Patients With Advanced Solid Tumors

Toronto : Novartis Investigative Site

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

Toronto : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Toronto : Local Institution

Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers

Toronto : Local Institution

Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors

Toronto : Investigational Site Number 124003

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Toronto : Princess Margaret Hospital - University Health Network Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Toronto : Sunnybrook Health Sciences Centre Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Toronto : UHN Princess Margaret Hospital

Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy

Toronto : Sunnybrook Health Sciences Centre

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Toronto : Investigational Site

Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma

Toronto : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Toronto : 1200.75.11003 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Toronto : 1200.67.11004 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Toronto : Princess Margaret Hospital

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Toronto : Investigational Site Number 124003

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Toronto : Investigational Site Number 124002

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Toronto : Novartis Investigative Site

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

Toronto :

Sorafenib Long Term Extension Program (STEP)

Toronto : Pfizer Investigational Site

Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Toronto : Investigational Site Number 124003 Updated

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Truro : GSK Investigational Site

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Vancouver : British Columbia Cancer Agency

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Vancouver : Novartis Investigative Site

A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors

Vancouver : Updated

A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer

Vancouver : Local Institution

Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors

Vancouver : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Vancouver : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Vancouver : 1200.131.00152 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Vancouver : 1200.123.1002 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Vancouver : Investigational Site Number 124001

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Vancouver : University of British Columbia

Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases

Vancouver : GSK Investigational Site

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Vancouver : British Columbia Cancer Agency, Vancouver Center

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Vancouver : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Vancouver : Vancouver General Hospital

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Victoria : Pacific Urologic Research Updated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Victoria : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Windsor : 1200.131.00151 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Winnipeg : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Winnipeg : CancerCare Manitoba

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Paraiso : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Providencia, Santiago : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Santiago : Merck Sharp & Dohme (I.A.) Corp.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Santiago : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Temuco : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

View More »

Temuco : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Temuco : 1200.75.56001 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Beijing : Pfizer Investigational Site

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

Beijing : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma

Beijing : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Beijing : Pfizer Investigational Site

Aromasin® Non-Interventional Study Of Early Invasive Breast Cancer Patients In China

Beijing : Updated

Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy

View More »

Beijing : Pfizer Investigational Site

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Beijing : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Beijing : 1200.75.86001 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Beijing : 1200.75.86002 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Beijing : 1200.75.86003 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Beijing : 1200.75.86004 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Beijing : 1200.75.86005 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Beijing : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Bejing : Pfizer Investigational Site

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

Changchun : 1200.75.86008 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Chendu : Department of oral and maxillofacial surgery, Huaxi university of medical science

p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage

Chengdu : 1200.75.86021 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Chengdu : West China Hospital, Sichuan University

rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors

Chongqing : Pfizer Investigational Site

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

Dalian : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Fuzhou : 1200.75.86019 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Fuzhou : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Guangzhou : Pfizer Investigational Site

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

Guangzhou : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Guangzhou : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Guangzhou : Sun Yat-Sen University Cancer Center

Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors

Guangzhou : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Guangzhou : 1200.75.86016 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Guangzhou : 1200.75.86018 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Guangzhou : 1200.75.86017 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Guangzhou : Novartis Investigative Site

Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor

Guangzhou : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

GuangZhou : Cancer Center of Sun-Yat Sen University (CCSYSU)

Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy

Haerbin : 1200.75.86022 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Hangzhou : Pfizer Investigational Site

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

Hangzhou : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Hangzhou : 1200.75.86012 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Hangzhou : 1200.75.86013 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Hangzhou : GCP center,First Affiliated Hospital of Zhejiang University

Safety Study of FLP Injection to Treat Tumor Patients

Hong Kong : Queen Elizabeth Hospital

Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery

Hong Kong : Department of Urology, Prince of Wales Hospital

Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Jiangsu : Jiangsu Province Hospital

Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence

Jinan : 1200.75.86015 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Nanjing : Jiangsu Provincial Centre for Disease Control and Prevention

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Nanjing : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Nanjing : 1200.75.86011 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Shanghai : Pfizer Investigational Site

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

Shanghai : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Shanghai : 1200.75.86010 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Shanghai : 1200.75.86009 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Shanghai : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Shanghai : Sanofi-Aventis Administrative Office

Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial

Tianjin : Pfizer Investigational Site

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

Tianjin : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Tianjin : 1200.75.86006 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Tianjin : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Wuhan : GSK Investigational Site

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Wuhan : 1200.75.86020 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Wuhan : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Xi'an : Dept. Resp. Diseases, Xijing Hospital

Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)

Bogota : Frosst Laboratories Inc.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Floridablanca-Santander : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Montería : Updated

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Pula : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Split : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Zagreb : Merck Sharp & Dohme IDEA, Inc.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Zagreb : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Zagreb : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Benesov :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Benešov : Updated

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Brno : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Brno : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Brno : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

View More »

Ceske Budejovice :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Ceske Budejovice : 1200.75.42004 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

České Budějovice : Updated

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Hradec Kralove : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Hradec Kralove :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Jicin : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Jihlava : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Most :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Nemocnicni :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Nemocnicni : Updated

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Olomouc : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Olomouc : 1200.75.42003 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Olomouc : 1200.43.04202 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Olomouc : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Olomouc : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Ostrava-Poruba :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Plesi :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Plzen :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Prague : Synta Pharmaceuticals Investigative Site

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

Prague 2 : 1200.75.42001 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Prague 2 : 1200.43.04203 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Prague 8 : 1200.43.04201 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Praha : Merck Sharp & Dohme IDEA Inc.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Praha 2 : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Praha 2 : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Praha 4 : 1200.75.42002 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Praha 5 : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Praha 8 : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Sokolov : Updated

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Sumperk : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Teplice :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Teplice : Updated

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Aalborg : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Aalborg : Dept. of Breast Surgery; Aalborg Sygehus

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Aarhus : Department of Oncology

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Århus : Dept. of Oncology; Århus Sygehus

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Århus : Dept. of Surgery; Århus Sygehus

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

View More »

Århus N : Childrens Department of Oncology A4, Aarhus Universityhospital, Skejby

Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia

Copenhagen : Rigshospitalet, Finsen Centret

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Copenhagen : Dept. of Oncology; Rigshospitalet

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Copenhagen : Dept. of Breast Surgery; Rigshospitalet

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Esbjerg : Dept. of Oncology; Sydvestjysk Sygehus Esbjerg

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Esbjerg : Dept. of Surgery; Sydvestjysk Sygehus Esbjerg

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Herlev : Herlev Hospital

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Herlev : Dept. of Oncology; Herlev Hospital

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Herlev : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Herlev : Dept. of Breast Surgery; Herlev Hospital

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Herning : Dept. of Oncology; Regionshospitalet Herning

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Hillerød : Dept. of Oncology; Nordsjællands Hospital Hillerød

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Holbaek : Pharmacosmos

A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoeisis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

København Ø : 1200.43.04501 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Næstved : Næstved Sygehus

A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoeisis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Næstved : Dept. of Oncology; Sygehus Syd Næstved

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Odense : Department of Oncology, Odense University Hospital

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Odense : Dept. of Oncology; Odense University Hospital

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Odense : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Odense : Dept. of Oncology; Odense University Hospital

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Ringsted : Depart. of Breast Surgery, Ringsted Sygehus

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Rønne : Dept. of internal medicine; Bornholms Hospital

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Roskilde : Dept. of Oncology; Sygehus Øst Roskilde

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Vejle : Dept. of Oncology; Vejle Sygehus

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Vejle : Dept. of Breast Surgery; Vejle Sygehus

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Viborg : Dept. of Oncology; Regionshospitalet Viborg

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer

Viborg : Dept. of Breast Surgery; Regionshospitalet Viborg

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Quito : Merck Sharp and Dohme (I.A.) Corp. Ecuador

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Tallinn : Merck Sharp & Dohme IDEA, Inc.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Tallinn : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Helsinki : Docrates Hospital

CGTG-102 for Therapy of Advanced Cancers

Helsinki : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Helsinki : 1200.67.35801 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Helsinki : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

HUS : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

View More »

Jyvaskyla : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Kotka : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Kouvola : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Kuopio : Kuopio University Hospital

Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer

Kuopio : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Kuopio : 1200.67.35804 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Lahti : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Lahti : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Lappeenranta : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Mikkeli : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Oulu : Oulu Univerity Hospital

Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer

Oulu : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Oulu : 1200.131.35853 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Pori : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Rauma : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Seinajoki : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Tampere : University of Tampere

Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer

Tampere : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Tampere : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Tampere : 1200.67.35802 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Tampere : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Turku : Department of Oncology and Radiotherapy, turku University Hospital

Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer

Turku : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Turku : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Turku : 1200.67.35803 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Turku : 1200.131.35851 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Turku : Research Site

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

Vaasa : Vaasa Distric Hospital

Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer

Vaasa : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Amiens Cedex 1 : 1200.75.33020 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Angers : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Angers : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Angers Cedex 9 : 1200.75.33011 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Annecy : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

View More »

Avignon : 1200.43.03304 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Bayonne : 1200.123.3307 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Besançon Cedex : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Besançon Cedex : 1200.75.33007 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Besançon Cedex : 1200.131.03358 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Bordeaux :

A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia

Bordeaux : Service de chirurgie digestive - hôpital Saint André - 1 rue Jean Burguet

Local Excision in Downstaged Rectal Cancer

Bordeaux : Service de Chirurgie Oncologique - Institut Bergonié - 229, cours de l'Argonne

Local Excision in Downstaged Rectal Cancer

Bordeaux : Service de Radiothérapie - Clinique Tivoli - 220 rue Mandron

Local Excision in Downstaged Rectal Cancer

Bordeaux : 1200.75.33015 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Bordeaux : 1200.75.33009 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Bordeaux : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Bordeaux :

Sorafenib Long Term Extension Program (STEP)

Bordeaux : Institute Bergonié

Trial of MSC1936369B in Subjects With Solid Tumours

Bordeaux Cedex : Novartis Investigative Site Updated

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

Boulogne Billancourt : Service de Chirurgie Digestive - Hôpital ambroise Paré - 9 avenue Charles de Gaulle

Local Excision in Downstaged Rectal Cancer

Bourgogne : Center Alexis Vaurrin

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Brest cedex : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Bretonneau Tours : Centre Hospitalier Régional et Universitaire - Hôpital

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Bron Cedex : Novartis Investigative Site

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Caen : Centre François Baclesse

Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis

Caen : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Caen Cedex 05 : 1200.123.3305 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Caen Cedex 05 : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Castelnau Le Lez : Clinique du Parc CASTELNAU LE LEZ

National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients

Clermont Ferrand Cedex 1 : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Clermont-Ferrand : Service de Chirurgie Générale et Digestive - Hôtel Dieu - CHU Clermont-Ferrand - Boulevard Léon Malfreyt

Local Excision in Downstaged Rectal Cancer

Clermont-Ferrand : Département de Radiothérapie - Centre Jean Perrin - 58 rue Montalembert

Local Excision in Downstaged Rectal Cancer

Clermont-Ferrand Cedex : 1200.75.33006 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Clermont-Ferrand cedex 1 : 1200.67.33010 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Clermont-Ferrand cedex 1 : 1200.43.03306 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Clichy : Service de Chirurgie Générale et Digestive - Hôpital Beaujon - 100 boulevard du Général Leclerc

Local Excision in Downstaged Rectal Cancer

Clichy Cedex : 1200.131.03360 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Colmar : Hôpitaux Civils de Colmar-CH Louis Pasteur

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Colmar : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Courbevoie : Laboratoires Merck Sharp & Dohme - Chibret

Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)

Courbevoie : Laboratoires Merck Sharp & Dohme - Chibret

Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)

Dijon : 1200.93.33002 Boehringer Ingelheim Investigational Site

A Phase I Dose Escalation Trial of Afanitib Plus Gemcitabine or Afatinib Plus Docetaxel

Dijon : Centre Georges-François Leclerc Updated

Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma

Dijon Cedex : 1200.75.33019 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Dijon Cedex : 1200.43.03312 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Ferolles-Attilly : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Grenoble : 1200.75.33017 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

La Roche sur Yon : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

La Roche Sur Yon Cedex 9 : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

La Tronche : Service de Chirurgie Digestive - Hôpital A. Michallon - CHU de Grenoble - Boulevard de la Chantourne

Local Excision in Downstaged Rectal Cancer

Le Havre : 1200.131.03353 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Le Mans : 1200.75.33014 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Lille : Department of Obstetrics and Gyneacology, Lille University Hospital

Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1

Lille : Département de Chirurgie Oncologique - Centre Oscar Lambret - 3 rue Combemale

Local Excision in Downstaged Rectal Cancer

Lille : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Lille Cedex : 1200.75.33005 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Lille Cedex : 1200.67.33008 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Lille Cedex : 1200.43.03303 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Lille Cedex : 1200.131.03351 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Lille Cedex : Investigational Site Number 250002 Updated

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Limoges Cedex : 1200.75.33010 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Limoges Cedex : 1200.123.3308 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Limoges Cedex : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Lyon : Novartis Investigative Site

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Lyon :

A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia

Lyon :

A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Patients With Advanced Solid Tumors

Lyon : Département de Chirurgie Oncologique - Centre Léon Bérard - 28 rue Laennec

Local Excision in Downstaged Rectal Cancer

Lyon : Service de Chirurgie Générale - Hôpitaux Civils de Lyon

Local Excision in Downstaged Rectal Cancer

Lyon : Centre Hospitalier Lyon Sud

Phase I Study of mPEG-R-Crisantaspase Given IV

Lyon : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Lyon Cedex : Novartis Investigative Site

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma

Lyon Cedex : 1200.43.03301 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Lyon Cedex : Hospital Edouard Herriot, Service d'Hematologie Clinique

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Lyon Cedex 08 : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Lyon Cedex 08 : 1200.67.33001 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Lyon Cedex 08 : 1200.123.3301 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Lyon Cedex 3 : Hopital Edouard Herriot

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Marseille : Institut Paoli Calmette

Local Excision in Downstaged Rectal Cancer

Marseille : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Marseille : Investigational Site Number 250003 Updated

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Marseille Cedex 09 : 1200.67.33004 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Marseille Cedex 20 : Updated

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies

Marseille Cedex 5 : 1200.131.03362 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Marseille Cedex 5 : Novartis Investigative Site

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Montbéliard Cedex : 1200.131.03361 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Montellier cedex 5 : Novartis Investigative Site Updated

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

Montpellier : Département de Chirurgie Oncologique - CRLC Val d'Aurelle

Local Excision in Downstaged Rectal Cancer

Montpellier cedex 5 : 1200.43.03302 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Montpellier Cedex 5 : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Nantes : Novartis Investigative Site

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Nantes : 1200.75.33013 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Nantes : Hospital Hotel Dieu, Service D'Hematologie

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Nantes Cedex 01 : Investigational Site Number 250005 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Nantes Cedex 2 : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Nantes-Saint Herblain : Centre René Gauducheau

Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma

Nice : Centre Antoine Lacassagne

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Nice : Service de Chirurgie Générale - Hôpital Archet II

Local Excision in Downstaged Rectal Cancer

Nice Cedex 02 : 1200.67.33011 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Nice cedex 2 : 1200.43.03307 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Nice cedex 2 : 1200.131.03359 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Nimes : Investigational Site Number 250004 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Paris : Novartis Investigative Site

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Paris :

A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors

Paris : Research Site

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Paris : Service de Chirurgie Digestive - Hôpital des Diaconnesses - la Croix Saint-Simon - 125 rue d'Avron

Local Excision in Downstaged Rectal Cancer

Paris : Service de Chirurgie Générale et Digestive - Hôpital Saint-Antoine - 184 rue du Faubourg Saint-Antoine

Local Excision in Downstaged Rectal Cancer

Paris : Service d'Oncologie - Radiothérapie - Hôpital Tenon - 4 rue de la Chine

Local Excision in Downstaged Rectal Cancer

Paris : Service de Cancérologie - Radiothérapie - Hôpital Saint-Louis - 1 avenue Claude Vellefeaux

Local Excision in Downstaged Rectal Cancer

Paris : Département Médico-Chirurgical de Pathologie Digestive - Hôpital Lariboisière - 2 rue Ambroise Paré

Local Excision in Downstaged Rectal Cancer

Paris : 1200.75.33012 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Paris : 1200.67.33003 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Paris : 1200.123.3303 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Paris : Institut Curie

Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis

Paris : Hospital Saint Louis, Service D'Hematologie

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Paris : Hôpital Beaujon

Trial of MSC1936369B in Subjects With Solid Tumours

Paris : Hopital Saint Louis

Trial of MSC1936369B in Subjects With Solid Tumours

Paris Cedex 05 : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Paris Cedex 05 : 1200.67.33002 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Paris Cedex 05 : 1200.43.03314 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Paris Cedex 10 : Investigational Site Number 250001 Updated

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Paris Cedex 8 : Laboratoires Merck Sharp & Dohme - Chibret

A Study of Ridaforolimus in Pediatric Patients With Advanced Solid Tumors (MK-8669-056)

Paris Cedex 8 : Laboratoires Merck Sharp & Dohme - Chibret

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Pessac : CHU du Haut-Leveque, Service des Matadies du Sang Unite de Recherche Clinique

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Pessac Cedex : Research Site Updated

GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Pierre Benite : Service de Radiothérapie - Oncologie - Centre Hospitalier Lyon Sud - Hôpitaux Civils de Lyon - 165 chemin du Grand Revoyet

Local Excision in Downstaged Rectal Cancer

Pierre Benite Cedex : Research Site Updated

A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

Pierre Benite Cedex : Investigational Site Number 250002 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Pierre Benite Cedex : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Pierre Benite Cedex : Research Site

Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours

Pierre-Bénite : 1200.131.03355 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Poitiers : 1200.43.03305 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Poitiers Cedex :

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Reims : Institute Jean Godinot

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Reims : 1200.75.33001 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Reims : 1200.75.33018 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Rennes : Service de Chirurgie Viscérale - CHU pontchaillou - 2 rue Henri Le Guilloux

Local Excision in Downstaged Rectal Cancer

Rennes : Centre Eugène Marquis

Trial of MSC1936369B in Subjects With Solid Tumours

Rennes Cedex : CHU de Pontchaillou-CIC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Rennes Cedex : 1200.75.33016 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Rouen : Centre Hospitalier Universitaire de Rouen

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Rouen : CHU Rouen

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Rouen : Service de Chirurgie Digestive - CHU Charles Nicolle - 1 rue Germont

Local Excision in Downstaged Rectal Cancer

Rouen : Centre Henri Becquerel

Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis

Rouen Cedex 1 : 1200.43.03316 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Saint Herblain : Service de Chirurgie Oncologique - Centre René Gauducheau - Boulevard Jacques Monod

Local Excision in Downstaged Rectal Cancer

Saint Herblain Cedex : 1200.67.33005 Boehringer Ingelheim Investigational Site

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Saint Herblain Cedex : 1200.43.03309 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Saint Herblain Cedex : 1200.131.03354 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Saint Herblain Cedex : 1200.123.3302 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Sainte Foy les Lyon : Service de Chirurgie Viscérale - Clinique Charcot - 51-52 rue Commandant Charcot

Local Excision in Downstaged Rectal Cancer

Saint-Herblain : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Saint-Herblain cedex : 1200.93.33001 Boehringer Ingelheim Investigational Site

A Phase I Dose Escalation Trial of Afanitib Plus Gemcitabine or Afatinib Plus Docetaxel

Saint-Pierre Cedex -La Réunion : 1200.123.3306 Boehringer Ingelheim Investigational Site

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

St Herblain : Centre René Gauducheau

Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis

St. Etienne Cedex 2 : Clinique Mutualiste

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

St. Herblain Cedex : Medicale Centre René Gauducheau

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Strasbourg : Service de Chirurgie Digestive - Hôpital Hautepierre

Local Excision in Downstaged Rectal Cancer

Strasbourg : Hopitaux Universitaires de Strasbourg, CHU Haute-Pierre

Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence

Strasbourg : University Hospital of Strasbourg

Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases

Strasbourg : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Strasbourg : Novartis Investigative Site

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Strasbourg Cedex : 1200.75.33008 Boehringer Ingelheim Investigational Site

LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment

Suresnes Cedex :

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Toulouse : Novartis Investigative Sie

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Toulouse :

A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors

Toulouse :

A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Patients With Advanced Solid Tumors

Toulouse : Investigational Site Number 250003 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Toulouse : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Toulouse : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Toulouse : Institut Claudius Regaud Updated

Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma

Toulouse : Institute Claudius Regaud

Trial of MSC1936369B in Subjects With Solid Tumours

Toulouse Cedex : 1200.93.33003 Boehringer Ingelheim Investigational Site

A Phase I Dose Escalation Trial of Afanitib Plus Gemcitabine or Afatinib Plus Docetaxel

Toulouse Cedex : Investigational Site Number 250001

First in Man Study of SAR566658 Administered Every 3 Weeks in Patients With DS6-positive and Refractory Solid Tumors

Tours : 1200.131.03356 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Vandoeuvre les Nancy : Service de Chirurgie Digestive et Générale - CHU Brabois - avenue de Bourgogne

Local Excision in Downstaged Rectal Cancer

Vandoeuvre les Nancy cedex : 1200.43.03310 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Villejuif : Novartis Investigative Site

A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors

Villejuif :

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma

Villejuif : Institute Gustave Roussy

EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Villejuif : Institut Gustave-Roussy

Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma

Villejuif : Institut Gustave Roussy Updated

Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma

Villejuif : Institute Gustave Roussy

Study of Oral E-3810, a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors

Villejuif : Investigational Site Number 250001

Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors

Villejuif Cedex : Centre Hospitalier Universitaire, Institut Gustave Roussy

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Villejuif Cedex : Novartis Investigative Site

A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors

Villejuif Cedex : Novartis Investigative Site

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma

Villejuif Cedex : Updated

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies

Villejuif Cedex : Investigational Site Number 250001

Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors

Villejuif Cedex : 1200.43.03317 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Villejuif Cedex : 1200.131.03357 Boehringer Ingelheim Investigational Site

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Villejuif Cedex : Investigational Site Number 250001 Updated

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Villejuif Cedex : Novartis Investigative Site

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

Villejuif Cedex : Research Site

Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours

Villejuif Cedex : GSK Investigational Site

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Villejuif cedex : Research Site

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Villejuif, Cedex : Institut Gustave-Roussy (IGR)

Study of NMS-1116354 in Advanced/Metastatic Solid Tumors